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RIASSUNTO 
Il sistema autofagico-lisosomiale è un sistema di degradazione ubiquitario e 
conservato tra le diverse specie. Esso viene attivato dalla cellula per 
degradare proteine con lunga emivita, organelli danneggiati e porzioni 
citoplasmatiche, che vengono sequestrate da un network di vescicole a 
doppia membrana, dette autofagosomi. Gli autofagosomi che contengono il 
materiale da degradare fondono con i lisosomi, dove il loro contenuto viene 
degradato e i prodotti riciclati per soddisfare la richiesta energetica 
cellulare. Il muscolo scheletrico è il tessuto più abbondante nei mammiferi e 
utilizza l’80% del glucosio presente nel corpo. Un efficiente sistema 
autofagico è necessario per il mantenimento della massa muscolare (Masiero 
et al., 2009). Durante l’invecchiamento, il tessuto muscolare subisce un 
inevitabile processo di atrofia, detto sarcopenia, che è indipendente 
dall’attività del soggetto ma si aggrava in condizioni di disuso (Rossi et al., 
2008). I meccanismi coinvolti nella perdita di massa muscolare non sono 
ancora stati individuati con chiarezza. Poiché l’autofagia diminuisce con l’età 
(Tan et al., 2013), abbiamo studiato il ruolo dell’autofagia durante 
l’invecchiamento del tessuto muscolare.  
In questo lavoro sono stati quindi caratterizzati topi knockout condizionali 
per il gene Atg7 (Atg7-/-), gene che codifica per un enzima critico per la 
formazione degli autofagosomi (Masiero et al., 2009). In questo modo è 
possibile ottenere il blocco del processo autofagico in modo specifico nel 
muscolo scheletrico. Questi animali e i rispettivi controlli sono stati 
analizzati durante l’invecchiamento. I topi Atg7-/- muoiono prima dei 
controlli e, da vecchi, presentano un fenotipo miopatico, in cui le condizioni 
di atrofia sono esacerbate rispetto agli animali Atg7-/- adulti. Misure di forza 
in vivo di questi animali hanno mostrato come gli animali Atg7-/- risultino più 
deboli dei controlli; inoltre, gli animali Atg7-/- adulti presentano la stessa 
forza dei controlli vecchi, suggerendo uno stato di indebolimento precoce. 
Poiché il sistema autofagico è importante per la rimozione degli organelli 
danneggiati, abbiamo studiato i mitocondri. Durante l’invecchiamento, i 
mitocondri dei muscoli Atg7-/- si accumulano e presentano un’alterata 
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morfologia alla microscopia elettronica. Abbiamo quindi analizzato la loro 
funzionalità misurando la capacità di mantenere il potenziale di membrana 
mitocondriale dopo l’aggiunta di un inibitore dell’ATP sintasi. I mitocondri 
degli Atg7-/- sono risultati incapaci di mantenere il potenziale, al contrario 
dei controlli. L’alterata funzionalità mitocondriale induce un aumento della 
produzione di ROS con conseguente stress ossidativo. Mediante un 
approccio di proteomica in collaborazione con il Prof. Friguet dell’Univeristà 
di Parigi, abbiamo caratterizzato le proteine ossidate e abbiamo trovato che 
le proteine contrattili, actina e miosina, erano le proteine maggiormente 
carbonilate nei topi vecchi knockout rispetto ai controlli della stessa età. Per 
capire se questa alterazione contribuisse alla debolezza muscolare di questi 
animali abbiamo eseguito saggi funzionali in collaborazione con il gruppo del 
Prof. Bottinelli dell’Università di Pavia. Misurazioni della forza sulle singole 
fibre e della velocità di scorrimento dei filamenti di actina/miosina hanno 
mostrato che gli Atg7-/- hanno capacità contrattili minori e alterazioni 
nell’interazione actina/miosina. 
Sebbene la presenza di fibre denervate sia fisiologica durante 
l’invecchiamento, gli animali adulti Atg7-/- presentano segni di denervazione 
precoce, indicata dall’aumento di espressione di markers specifici come 
Muscle Specific Kinase (MuSK), Acetylcholine Receptor gamma subunit 
(AchR-gamma) e Neural Cell Adhesion Molecule (NCAM); inoltre la loro 
espressione aumenta ulteriormente con l’età. Abbiamo quindi deciso di 
analizzare in dettaglio la giunzione neuromuscolare in collaborazione con il 
gruppo del Dr. Rudolf presso Karlsruhe Institute of Technology (KIT) a 
Karlsrhue. Esperimenti di in vivo imaging hanno mostrato che le giunzioni 
degli Atg7-/- sono instabili e frammentate. Tali alterazioni sono già ben 
evidenti in animali adulti Atg7-/- suggerendo nuovamente un processo di 
invecchiamento precoce dovuto al blocco autofagico. 
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Ci siamo poi focalizzati sul potenziale ruolo dello stress ossidativo nel generare e 
contribuire al fenotipo di questi animali. Abbiamo trattato gli animali per 30 giorni 
con un anti-ossidante (Trolox), analogo della vitamina E. Dopo il trattamento, le 
capacità contrattili di actina/miosina e di funzionalità mitocondriale sono tornate al 
livello dei controlli, mentre abbiamo osservato solo effetti minori sulla giunzione 
neuromuscolare e nessun miglioramento sull’ atrofia. Questi risultati indicano che lo 
stress ossidativo ha sicuramente un ruolo sulla funzionalità di proteine contrattili e 
dei mitocondri, ma che altri fattori sono implicati nel mantenimento della giunzione 
neuro-muscolare e nell’atrofia. Ci siamo quindi focalizzati su fattori neurotrofici 
secreti dal muscolo, che fossero alterati nei topi knockout, sia negli adulti che nei 
vecchi. Dopo uno screening mediante qRT-PCR abbiamo individuato FGF-binding 
protein 1 (FGFBP1) come l’unico fattore che risultava soppressonei topi Atg7-/- ad 
entrambe le età. FGFB1 è un importante attivatore di proteine FGFs coinvolte 
nell’organizzazione pre-sinaptica. A questo punto per capire il ruolo di FGFBP1, 
abbiamo effettuato esperimenti di silenziamento e di sovra-espressione in vivo. 
Inizialmenete abbiamo ridotto l’espressione di FGFBP1 in animali di controllo per 
mimare il fenotipo dei topi Atg7-/-. Due settimane di silenziamento sono state 
sufficienti per provocare instabilità e frammentazione della giunzione 
neuromuscolare. Successivamente abbiamo over-espresso FGFBP1 negli animali 
Atg7-/- per ristabilirne l’espressione ed abbiamo osservato un drastico 
miglioramento della stabilità della giunzione neuromuscolare. In ultimo, per far luce 
sul meccanismo che lega l’assenza di autofagia all’alterazione di FGFBP1, ci siamo 
concentrati su MuSK, una chinasi essenziale per la regolazione della maggior parte 
dei segnali implicati nello sviluppo e mantenimento della giunzione 
neuromuscolare. La localizzazione di MuSK risulta alterata negli animali Atg7-/- e il 
silenziamento di MuSK in vivo in animali di controllo porta all’abbattimento 
dell’espressione di FGFBP1. 
 
Questi risultati suggeriscono che il mantenimento della giunzione neuromuscolare 
richiede la secrezione di FGFBP1 da parte del muscolo e che l’autofagia è un 
processo critico per la giusta localizzazione e quindi attività di MuSK. 
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Diversi lavori hanno dimostrato come la restrizione calorica e l’esercizio fisico 
migliorino la qualità della vita, siano in grado di ritardare l’insorgenza di 
caratteristiche proprie dell’invecchiamento ed avere effetti benefici sul 
mantenimento della giunzione neuromuscolare (Melov et al., 2007; Fontana et al., 
2010; Sandri et al., 2013; Schiaffino et al., 2013; Coen et al., 2013; Toledo et al., 2013; 
Guarente, 2013). In letteratura sono presenti lavori che hanno analizzato il ruolo 
dell’autofagia nell’esercizio (He et al., 2012; Kim et al., 2013), essi però presentano 
risultati contrastanti. He et al. sostengono che l’autofagia sia richiesta per l’esercizio 
fisico e la regolazione dell’omeostasi del glucosio (He et al., 2009), al contario altri 
gruppi osservano un fenotipo opposto in animali in cui l’autofagia è assente 
costitutivamente nel muscolo scheletrico (Kim et al., 2013). In questo scenario, 
quindi, non è ancora chiaro il ruolo dell’autofagia durante l’esercizio e se gli effetti 
benefici dello stesso sono mediati da essa. Per investigare questo aspetto, abbiamo 
utilizzato animali in cui la delezione del gene Atg7, viene indotta specificamente nel 
muscolo scheletrico dopo somministrazione di Tamoxifen (Masiero et al., 2009). In 
questo modo è possibile escludere meccanismi di compensazione e adattamento 
presenti in modelli in cui le delezioni sono costitutive. Abbiamo deleto acutamente il 
gene Atg7 in animali adulti e, insieme ai rispettivi controlli, li abbiamo sottoposti ad 
un protocollo di esercizio concentrico su treadmill. Tuttavia non abbiamo osservato 
differenze nelle distanze percorse tra i due genotipi. Questo indica che l’autofagia 
non è richiesta per sostenere attività contrattile durante un normale esercizio 
concentrico. 
Abbiamo, poi, sottoposto gli animali ad un protocollo di tre giorni di esercizio 
eccentrico, per valutare se l’autofagia fosse invece richiesta per il mantenimento del 
tessuto muscolare in seguito a contrazioni che inducono danno. In questo caso 
abbiamo osservato che gli animali Atg7-/- corrono di meno rispetto ai controlli e, in 
particolare, questa differenza risulta significativa nelle femmine. Per investigare il 
motivo della ridotta performance abbiamo inizialmente analizzato la morfologia, 
senza però osservare segni di alterazione o infiammazione. Successivamente, 
abbiamo valutato aspetti metabolici, ma né i livelli di glicemia e di lattacidemia, né la 
fosforilazione della chinasi attivata da AMP (AMPK), uno dei maggiori indicatori di 
stress energetico, risultano differenti tra Atg7-/- e controlli dopo l’esercizio. 
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Dato che l’autofagia è richiesta per il mantenimento del pool mitocondriale, abbiamo 
analizzato se la funzionalità dei mitocondri fosse alterata dopo l’esercizio. In questo 
caso abbiamo confermato che la delezione acuta di Atg7 causa l’accumulo di 
mitocondri disfunzionanti, e che la loro percentuale aumentava dopo l’esercizio. La 
presenza di mitocondri anomali causa un aumento dello stress ossidativo. Infatti 
abbiamo potuto dimostrare una maggiore carbonilazione delle proteine e aumentati 
livelli di produzione di ROS dopo l’esercizio, nei topi Atg7-/- rispetto ai controlli. Per 
valutare gli effetti dello stress ossidativo abbiamo trattato gli animali per sei 
settimane con un anti-ossidante generico N-acetil-cisteina (NAC). 
Sorprendentemente, il trattamento si è rivelato dannoso per la performance degli 
animali di controllo e in più non è stato in grado di migliorare l’attività dei topi   
Atg7-/-. L’antiossidante ha causato, inoltre, l’accumulo di mitocondri disfunzionanti 
nei topi di controllo. Questi risultati sono stati confermati anche dopo un 
trattamento con un diverso anti-ossidante (Mito-TEMPO), ad azione specifica sui 
mitocondri.  
E’ riportato in letteratura che il trattamento con anti-ossidanti riduce i livelli di 
autofagia in animali di controllo e che livelli fisiologici di ROS svolgono funzioni 
critiche nel signalling cellulare (Underwood et al., 2010; Owusu-Ansah et al., 2013). 
Negli animali di controllo trattati con anti-ossidante sono state confermate queste 
evidenze, ed infatti l’autofagia era bloccata. Questa inibizione potrebbe essere la 
causa dell’accumulo di mitocondri disfunzionanati e della loro performance. 
 
Questi risultati sottolineano il ruolo dell’autofagia nel mantenimento della 
funzionalità mitocondriale durante contrazioni eccentriche. Inoltre definiscono che 
l’autofagia non è richiesta per il supporto energetico durante le normali contrazioni 
e che AMPK e i livelli ematici di glucosio non dipendono dall’ attività del sistema 
autofagico.
12 
 
 
13 
 
SUMMARY 
Autophagy is an ubiquitous degradation system, that is conserved through species. 
Cells activate autophagy to degrade long-lived proteins, damaged organelles or 
portions of cytoplasm, that are engulfed in double-membrane vesicles called 
autophagosomes, that ultimately fuse to lysosomes, where the cargo is degraded and 
breakdown products are recycled to sustain cellular energetic demands. 
Skeletal muscle is the most abundant tissue in mammals and controls 80% of the 
blood glucose. We have recently shown that an efficient autophagy is required for 
muscle mass maintenance (Masiero et al., 2009). 
During ageing, muscles inevitably undergo atrophy, a process named sarcopenia 
(Rossi et al. 2008). Moreover, it has been reported that autophagy declines with age 
(Tan et al., 2013). Since the mechanisms involved in age-related muscle loss remain 
obscure, we investigated whether autophagy impairment contributes to sarcopenia. 
In this work, the muscle-specific autophagy knockout (Atg7-/-MLC), that were 
recently generated in our laboratory, were characterized during ageing (Masiero et 
al., 2009). Aged Atg7-/- mice have reduced lifespan and exacerbated atrophic and 
myopathic phenotype. In vivo force measurements showed that they are weaker 
compared to age-matched control mice. Alteration of mitochondrial morphology is a 
typical feature of Atg7-/- muscles. Therefore, we studied mitochondrial function in 
adult mice. Mitochondria of Atg7-/- mice were dysfunctional, in fact they did not 
retain membrane potential upon inhibition of ATP synthase. This mitochondrial 
alteration induced an increase of oxidative stress. A proteomic approach on oxidized 
protein, in collaboration with Prof. Friguet at the University of Paris, revealed that 
contractile proteins, such as actin and myosin, were significantly more carbonylated 
when autophagy was blocked. Functional assays of force measurements on single 
isolated fibers and sliding properties of purified actin/myosin, performed in 
collaboration with Prof. Bottinelli at the University of Pavia, showed an impairment 
of these contractile proteins in Atg7-/- mice.  
Atg7-/- mice also undergo spontaneous denervation, as confirmed by upregulation of 
denervation markers, such as Muscle Specific Kinase (MuSK), Acetylcholine 
Receptor gamma subunit (AchR-gamma) and Neural Cell Adhesion Molecule 
(NCAM). Moreover, in collaboration with Dr. Rudolf at Karlsruhe Institute of 
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Technology (KIT), in Karlsrhue, we performed in vivo imaging of neuromuscular 
junction (NMJ), that revealed NMJ fragmentation and instability in autophagy-
deficient mice. These findings suggest that inhibition of autophagy specifically in 
muscle generates a series of events that affect NMJ and causes a precocious 
denervation, contributing to sarcopenia. Since oxidative stress is an important 
feature of Atg7-/- mice and is believed to contribute to ageing, we treated adult mice 
with an antioxidant vitamin E analogue (Trolox), for 30 days, and we monitored the 
effects on the phenotype of Atg7-/- muscles. Trolox treatment reduced the level of 
protein carbonylation, restored the sliding properties of actin and myosin and 
brought back the force to normal level. Mitochondria function was also ameliorated 
but we did not find any benefit on atrophy and NMJ morphology. However, there 
was a small amelioration on NMJ stability. 
These data showed that oxidative stress contributes only to some aspects of ageing 
features present in Atg7-/- mice. Therefore, other mechanisms are involved for the 
atrophy and the denervation aspects. We then hypothesized that muscles release 
neurotrophic factors that are critical for muscle-nerve interaction and stability. 
Initially, we tought for neurotrophic factors that were down-regulated in autophagy-
deficient muscle both in adult and old mice. qRT-PCR identified FGF binding protein 
1 (FGFBP1) to be the one that was always suppressed in Atg7-/- mice. FGFBP1 is 
protein involved in the bio-activation of FGF proteins, that are important pre-
synaptic organizers. In order to investigate the role of FGFBP1 in NMJ instability we 
used loss and gain of function approaches. Down-regulation of FGFBP1 in control 
mice induced instability and fragmentation of NMJ. On the contrary FGFBP1 over-
expression in Atg7-/- muscles reduced the number of denervated fibers and restored 
NMJ stability. Then we investigated the connection between autophagy impairment 
and FGFBP1 down-regulation, by analyzing MuSK activity, a kinase that is essential 
for NMJ maintenance. We observed an alterated MuSK clustering in NMJ of Atg7-/- 
mice. Moreover MuSK down-regulation in vivo leads to FGFBP1 suppression.  
 
These results suggest that NMJ requires the secretion of FGFBP1 neurotrophic factor 
that is under MuSK regulation and that autophagy is critical for a normal MuSK 
localization and activity. 
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It has been consistently demonstrated that two lifestyle adaptations, namely caloric 
restriction and exercise, are able to extend lifespan and, in parallel, to mitigate age-
related alterations in NMJ (Melov et al., 2007; Fontana et al., 2010; Sandri et al., 
2013; Schiaffino et al., 2013; Coen et al., 2013; Toledo et al., 2013; Guarente, 2013). 
Moreover, both these conditions promote autophagy activation in skeletal muscles 
and in other tissues. It has also been reported that autophagy is required for 
exercise itself and for training-induced adaptations in glucose homeostasis (He et al., 
2012). These findings remain controversial as skeletal muscle–specific autophagy-
knockout mice show the opposite phenotype (Kim et al., 2013). In this scenario, it is 
still unknown whether it is whole body or muscle specific autophagy that is required 
to sustain contraction, maintain glucose homeostasis, and trigger exercise-induced 
benefits. For this reason, we used Tamoxifen-inducible, muscle-specific, Atg7 
knockout mice (Atg7-/-HSA), that we have recently generated (Masiero et al., 2009), 
to investigate the role of autophagy in physical exercise. This inducible muscle-
specific genetic model allows to minimize the chance of any adaptations and 
compensations that usually occur with constitutive deletion of genes. In order to 
investigate whether acute block of autophagy in muscle affects exercise 
performance, controls and autophagy-deficient mice were exercised on a treadmill. 
We used a concentric exercise protocol while monitoring the maximum distance ran 
to exhaustion. Surprisingly, we did not find any significant differences in running 
capacity between controls and inducible Atg7-/-. Thus, autophagy is not required to 
sustain muscle contraction during concentric physical activity. We hypothesized 
whether a damaging eccentric-type muscle contraction might unravel a novel role 
for autophagy during muscle repair after exercise. So we performed repeated bouts 
of eccentric exercise to exhaustion for three consecutive days to induce damaging 
eccentric contraction in controls and inducible Atg7-/- animals, and found out that in 
these conditions, autophagy-deficient mice ran significantly less than controls. 
Morphological analyses did not show any sign of inflammation or myofibre 
degeneration, thus suggesting that impaired performance of Atg7-/- muscles was not 
due to major structural alterations. We also looked for possible energetic imbalance 
upon exercise, by monitoring the activity of P-AMPK, one of the major sensor of 
energetic stress, and by checking glucose and lactate levels in the blood. However, 
16 
 
no significant differences were observed, thus suggesting that autophagy is not 
required for metabolic regulation of skeletal muscle during exercise. Since 
autophagy is important for organelle quality control, we tested whether 
mitochondrial homeostasis was affected after exercise. Interestingly, isolated muscle 
fibers from inducible Atg7-/- animals contained dysfunctional mitochondria that well 
correlated with their impaired performance. Being mitochondria the main source of 
ROS in the cell, it was feasible to hypothesize that oxidative stress may play a role in 
this condition. To address that, we measured total protein carbonylation and ROS 
production in exercised muscles that indeed was higher in Atg7-/- muscles. All 
together these data showed that acute inhibition of autophagy led to accumulation 
of dysfunctional mitochondria, increased oxidative stress and reduced physical 
performance during eccentric contraction. Excessive oxidative stress impairs muscle 
function, thus potentially explaining the reduced physical performance of Atg7-/- 
mice. We therefore treated controls and inducible Atg7-/- mice with the anti-oxidant 
N-Acetyl Cysteine (NAC) for 6 weeks, and then exercised them eccentrically. 
Surprisingly, NAC treatment severely impaired performance of controls but did not 
elicit any benefit in inducible Atg7-/- animals. Moreover it impaired mitochondrial 
function of controls. This data were confirmed after treatment with another anti-
oxidant (Mito-TEMPO), that was specific for mitochondria. 
It has been reported that anti-oxidant treatment reduces activation of autophagy in 
control animals and that ROS are important for signalling pathways in the cell 
(Underwood et al., 2010; Owusu-Ansah et al., 2013). Our findings support these 
evidences, suggesting that physiological levels of ROS are important for the correct 
basal and stimulus-induced autophagy activation.  
 
Our results highlight the role of autophagy in the maintenance of mitochondrial 
function but not in AMPK activation and exercise dependent glucose homeostasis, 
suggesting that autophagy is an adaptive response to exercise that ensures 
mitochondria-quality control during damaging contractions. 
 
17 
 
1. INTRODUCTION 
1.1 SKELETAL MUSCLE 
1.1.1 Structure and function 
 
Skeletal muscle is the most abundant tissue in the whole organism, it represents 
almost 40% of the body weight and it is responsible for the body posture and 
movement. Skeletal muscle is composed by multinucleated and elongated cells 
called muscle fibres. Muscles fibres are organized in bundles and separated by 
specific membrane system. Each muscle is surrounded by a connective tissue 
membrane called epimysium; the muscle itself is formed by well organized bundles 
of muscle fibres that are grouped in fascicula and are surrounded by another layer of 
connective tissue, called perimysium. Within the fasciculus, each individual muscle 
fibre is surrounded by connective tissue called the endomysium (Figure 1). 
 
 
 
Fig.1: Schematic representation of skeletal muscle structure. 
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The plasma membrane surrounding muscle fibres is called sarcolemma.  
Each muscle fibre is formed by thousands of myofibrils, contains contractile proteins 
responsible for muscle contraction. The unit of muscle contraction is called 
sarcomere. Its structure was described first thank to microscopy techniques that 
individuated isotropic (light band) and anisotropic (dark band) zones, forming the 
specific striated aspect of the skeletal muscle. For this reason, sarcomere is usually 
defined as the segment between two neighbour Z-lines, that appears as a series of 
dark lines. Surrounding the Z-line, there is the region of the I-band (the light band). 
Following the I-band there is the A-band (the dark band). Within the A-band, there is 
a paler region called the H-band. Finally, inside the H-band there is a thin M-line, the 
middle of the sarcomere. These bands are not only morphological unit but also 
functional, because are characterized by the presence of different contractile 
proteins required for muscle contraction. In fact, actin filaments (thin filaments) are 
the major component of the I-band and extend into the A band. Myosin filaments 
(thick filaments) extend throughout the A-band and are thought to overlap in the M-
band. A huge protein, called titin, extends from the Z-line of the sarcomere, where it 
binds to the thin filament system, to the M-band, where it is thought to interact with 
the thick filaments. Several proteins important for the stability of the sarcomeric 
structure are found in the Z-line as well as in the M band of the sarcomere (Figure 
2). Actin filaments and titin molecules are cross-linked in the Z-disc via the Z-line 
protein alpha-actinin. The M-band myosin as well as the M proteins bridge the thick 
filament system to the M-band part of titin (the elastic filaments). Moreover several 
regulatory proteins, such as tropomyosin and troponin bind myosin molecules, 
modulating its capacity of contraction.  
 
Muscle contraction is due to the excitation-contraction coupling, by which an 
electrical stimulus is converted into mechanical contraction. The general scheme is 
that an action potential arrives to depolarize the cell membrane. By mechanisms 
specific to the muscle type, this depolarization results in an increase in cytosolic 
calcium that is called a calcium transient. This increase in calcium activates calcium-
sensitive contractile proteins that then use ATP to cause cell shortening. Concerning 
skeletal muscle, upon contraction, the A-bands do not change their length, whereas 
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the I bands and the H-zone shorten. This is called the sliding filament hypothesis, 
which is now widely accepted. There are projections from the thick filaments, called 
cross-bridges which contain the part (head) of myosin linked to actin. Myosin head 
is able to hydrolyze ATP and convering chemical energy into mechanical energy. The 
cross bridges are mostly oriented transverse to the fibre axis in relaxed fibres, while 
angled at around 45 degrees in rigor.  
 
 
 
Fig.2: Schematic representation of skeletal muscle sarcomere. 
 
To allow the simultaneous contraction of all sarcomeres, the sarcolemma penetrates 
into the cytoplasm of the muscle cell between myofibrils, forming membranous 
tubules called transverse tubules (T-tubules) (Figure 3). The T-tubules are 
electrically coupled with the terminal cisternae which continue into the 
sarcoplasmic reticulum. Thus the Sarcoplasmic Reticulum, which is the enlargement 
of smooth Endoplasmic Reticulum (ER) and which contains the majority of calcium 
ions required for contraction, extends from both sides of T-tubules into the 
myofibrils. Anatomically, the structure formed by T-tubules surrounded by two 
smooth ER cisternae is called the triad and it allows the transmission of membrane 
depolarization from the sarcolemma to the ER. The contraction starts when an 
action potential diffuses from the motor neuron to the sarcolemma and then it 
travels along T-tubules until it reaches the sarcoplasmic reticulum. Here the action 
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potential changes the permeability of the sarcoplasmic reticulum, allowing the flow 
of calcium ions into the cytosol between the myofibrils. The release of calcium ions 
induces the myosin heads to interact with the actin, allowing the muscle contraction. 
The contraction process is ATP dependent. The energy is provided by mitochondria 
which are located closed to Z line. 
 
 
Fig.3: Schematic representation of organization of T-tubuls in skeletal muscle. 
 
The contraction properties of a muscle depend on the fibre type composition. 
Mammalian muscle fibres are divided into two distinct classes: type I, also called 
slow fibres, and type II, called fast fibres. This classification considers only the 
mechanical properties. However the different fibre types also show peculiar features 
such as for example myosin ATPase enzymes, metabolism (oxidative or glycolitic), 
mitochondrial content revealed by succinate dehydrogenase (SDH) staining, and 
resistance to fatigue (Pette and Heilmann, 1979; Schiaffino et al., 2007). Each muscle 
is composed by a combination of fibre types, whose abundance affects the type of 
contraction the muscle undergoes (solw or fast); regarding that a muscle is defined 
as slow, if it containing more type I fibres, or fast, if type II fibres are more abundant. 
The different fibre types are also characterized by peculiar Myosin Heavy Chain 
(MHC) proteins expression. The fibre type I expresses the slow isoform of MHC 
(MHCβ or MHC1), and shows a great content of mitochondria, high levels of 
myoglobin, high capillary densities and high oxidative capacity. Muscles containing 
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many type I fibres display red colour for the great vascularisation and for the high 
myoglobin content. The type II, fast, myofibers are divided in three groups 
depending on which myosin is expressed. In fact distinct genes encode for MHC IIa, 
IIx (also called IId) and IIb. Type IIa myofibers are faster than type I, but they are 
still relatively fatigue-resistant. IIa fibers are relatively slower than IIx and IIb and 
have an oxidative metabolism due to the rich content of mitochondria (Schiaffino 
and Reggiani, 1996). Given all these characteristics, IIa fibres are also termed fast 
oxidative fibres. They exhibit fast contraction, high oxidative capacity and a relative 
fatigue resistance. The IIx and IIb fibre types are called fast-glycolitic fibres and 
show a prominent glycolitic metabolism containing few mitochondria of small size, 
high myosin ATPase activity, expression of MHC IIb and MHC IIx proteins, the fastest 
rate of contraction and the highest level of fatigability. 
The fibre-type profile of different muscles is initially established during 
development independently of neural influence, but nerve activity has a major role 
in the maintenance and modulation of its properties in adult muscle. Indeed during 
postnatal development and regeneration, a default nerve activity-independent 
pathway of muscle fibre differentiation, which is controlled by thyroid hormone, 
leads to the activation of a fast gene program. On the contrary, the post natal 
induction and maintenance of the slow gene program is dependent on slow 
motoneuron activity. The muscle fibre-type then undergoes further changes during 
postnatal life, for example fibre-type switching could be induced in adult skeletal 
muscles by changes in nerve activity (Murgia et al., 2000).  
 
1.1.2 The Nerve-Muscle connection 
 
Neuromuscular Junction (NMJ) development and maintenance  
 
The vertebrate skeletal neuromuscular junction (NMJ) is the connection between 
motor neurons and skeletal muscle.  
NMJ is the most used model in the study of single synapse, because it has a clearly 
defined organization and it is quite accessible thanks to its relatively large size and 
localization. NMJ lies outside the brain and post-synaptic muscle fibre is generally 
innervated by one axon. Muscles are readily re-innervated following nerve damage, 
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allowing synaptogenesis to be studied also in adult and not only in embryonic 
organisms. Moreover, the bond between bungarotoxins (BGT) and AChR is able to 
clearly identify the localization and the morphology of NMJ.   
The general structure of NMJ can be described in three zones. The pre-synaptic 
element is the motorneuron, it contains mitochondria and synaptic vesicles that 
reach the pre-synaptic membrane in correspondence of synaptic buttons. Those 
buttons are distributed along an elliptical area that takes the name of endplate 
terminal, it represent the active zone since it is where the neurotransmitter 
acetylcholine (ACh) is released. Muscle fibre is the post-synaptic element. It is 
characterized by junctional folds rich of nicotinic acetylcholine receptor (AChR) and 
Voltage-gated Na+ channels. The synaptic cleft is the space between pre- and post- 
synaptic elements, where ACh is released from the active zone (Figure 4). 
 
 
 
Fig.4: Schematic representation of NMJ structure, where pre-synaptic (nerve), and post-
synaptic (muscle fibre) elements are described.  
 
The generation of new synapses starts at embryonic stage (17-19 days) with the 
extension of motoneuron’s axon, that branches to innervate a variable number of 
skeletal muscle fibres in a discrete central region of each one named the end-plate 
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band. The nerve terminal accumulates synaptic acetylcholine vesicles and other pre-
synaptic components, and while both pre- and post- synaptic membranes thicken, 
the synaptic cleft widens. With increasing number of vesicles, the active zone starts 
to appear and, the expression of several genes, coding for postsynaptic proteins, 
including the acetylcholine receptors (AChRs), increases in the postsynaptic nuclei. 
The last step of this process is axon myelination and junctional fold formation in the 
post-synaptic element (Figure 5). These morphological changes in the nerve 
terminal are accompanied by increased frequency of spontaneous synaptic 
potential.  
 
 
 
 
Fig.5: Morphological changes in NMJ development A) Representation of NMJ developmental 
stages, in details (a-b) is reported the nuclei transition from extra-synaptic to the synaptic 
region, where a specific transcriptional programme is activated. B) Morphological changes in 
NMJ that from embrionic-oval stage became pretzel-shaped in the adult and mature one (Shi et 
al., 2012). 
 
The development of neuromuscular junction requires a fundamental process called 
muscle pre-patterning that is characterized by both muscle- and nerve-specific 
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dependent mechanisms. Muscle pre-patterning is the process in which AChRs 
aggregate at the end-plate band of muscle during the earliest stages of NMJ 
development at the prospective synaptic region (Figure 6). AChRs accumulate and 
specifically cluster in a specific region of the muscle fibre that will be where the 
future NMJ will originate. This process can be divided in two stages: muscle-specific 
processes, that start before innervation, and nerve dependent events that occur 
after muscle/nerve contact. 
 
 
 
Fig.6: Representation of muscle pre-patterning (Burden, 2011). 
 
The major factors involved in the muscle-specific part are the expression and 
localization of MuSK, a muscle specific tyrosine kinase receptor. Its expression is 
required in the central region of the end-plate, where it could be initially auto-
activated itself, without any ligand. MuSK activation promotes its own clustering 
first (with a positive loop) and AChR later, in correspondence of the future synaptic 
zones (Burden, 2011). In this scenario, L-type Ca2+ channel DHPR receptor is also 
expressed in muscle, because it regulates the expression and localization of AChR 
and MuSK, through Ca2+ influx, not depending on the role in excitation-contraction 
coupling (Chen et al., 2011). Also WNT pathway, in particular with the factor 
WNT11, promotes clustering of AChR precursor, by binding and activating MuSK 
(Henríquez et al., 2011; Wu et al., 2010). At a later stage, when a growing neuron 
approaches the myotube, AChR clusters start to aggregate near the region of nerve 
contact. This means that AChR cluster become restricted to the sub-synaptic 
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membrane, thus disappearing from the extra-synaptic one, and that AChR subunits 
composition change from α2, β, δ, γ to α2, β, δ, ε resulting in acquisition of new 
channel properties (Hall and Sanes, 1993; Numberger et al., 1991). AChR-ɣ subunit 
is in fact a defined marker of reinnervation, because it is typical of early 
developmental stages of NMJ. So when the nerve establishes contact with a muscle 
cell, it exerts complex control over both number and distribution of AChRs.  
There is another way in which nerve controls post-synaptic differentiation, in fact 
the system that regulates the density of extra-synaptic AChR is based on electrical 
activity evoked by synaptic transmission. When the nerve depolarizes the muscle, 
the action potential represses AChR gene transcription in extra synaptic nuclei, 
probably through Ca2+, protein kinase C and MYOD transcription factor, thus having 
AChR expression specifically localized at synaptic zones. In addition, nerve terminal 
can also contribute with secretion of other factors that can act locally via different 
receptors (Wu et al., 2010; Hall and Sanes, 1993).  
After the pre-patterning, post-synaptic differentiation takes place depending on the 
clustering of neurotransmitter (NT) receptors and scaffolding proteins. These 
changes are regulated by different signals including WNT pathway, and 
neurotrophins secreted from the nerve. An important role is played by a molecule 
called neuregulin that is secreted from the neuron, and binds muscle receptor ErbB 
to induce the activation of synaptic genes (Burden, 2002; Trinidad et al., 2000). The 
most important and studied signalling pathway involved in post-synaptic 
differentiation is the MuSK/Agrin signalling (Figure 7). MuSK, as already said, is a 
tyrosine kinase receptor expressed in the postsynaptic membrane of NMJ, where it 
co-localizes with AChRs, inducing their clustering (Kim and Burden, 2008). MuSK is 
activated by Agrin, a proteoglycan released from the nerve, that stimulate MuSK 
phosporylation, by interacting with Lrp4 and not directly with MuSK. Lrp4 is a 
lipoprotein receptor related protein 4, and acts as co-receptor, for the Agrin-MuSK 
signal. Lrp4 self-associates and interacts with MuSK also in the absence of Agrin. 
Binding of Agrin to Lrp4 stimulates association between Lrp4 and MuSK and 
increases MuSK kinase activity. Then MuSK stimulates recruitment of Dok-7 that is 
cytoplasmic adaptor protein expressed specifically in muscle. MuSK promotes Dok-7 
tyrosine phosphorylation, and after that Dok-7 is able to form a dimer and with a 
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positive feedback stimulates MuSK kinase activity. Formation of a MuSK/Dok-7-
signaling complex is essential to activate both a Rac/Rho-dependent and a Rapsyn-
dependent pathway, which leads to the anchoring and clustering of AChRs (Burden, 
2011).  
 
 
 
Fig.7: Representation of MuSK/Agrin signalling, that involve Dok-7 and Rapsyn as regulatory 
an scaffolding protein and leads to AChR clustering (Burden, 2011). 
 
So, nerve is essential for post-synaptic differentiation and muscle tissue 
characterization, but in the last few years several studies have suggested an 
emerging larger role for the muscle, in particular in the control and maintenance of 
the pre-synaptic element through specific retrograde signal (Figure 8). This 
regulation occurs both during NMJ development and during re-innervation after 
injury. Different mechanisms have been identified to be clearly involved in pre-
synaptic differentiation.  
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Fig.8: Signals in Nerve-Muscle communication. Several nerve-produced signals important for 
post-synaptic development (green arrow) and muscle-secreted retrograde factors involved in 
pre-synaptic development and maintenance (modified from Johnson-Venkatesh and Umemori, 
2010).  
 
Laminin beta-2 is a protein of the synaptic basal lamina, that binds voltage gated 
Ca2+ channels of the neuron mediating pre-synaptic maturation. The molecules FGF -
7-10-22 are important pre-synaptic organizers, that are secreted from the muscles, 
bind the FGF receptor 2b and stimulate synaptic vesicle clustering and therefore the 
onset of the pre-synaptic terminal. Ephrin-A is a protein expressed by the muscle 
and contributes to the correct position of NMJ formation. In the end, Collagen IV, 
located at the synaptic basal lamina, is also involved in mechanisms of synaptic 
maintenance (Johnson-Venkatesh and Umemori, 2010; Fox et al., 2007; Burden, 
2000). Finally both the muscle-specific molecules MuSK and Lrp4, besides being 
fundamental for muscle pre-patterning, are required for pre-synaptic differentiation 
(Yumoto et al., 2012; Gomez and Burden, 2011; Kim et al., 2008).  
Recent studies pointed out the role of muscle tissue not only during muscle 
development but also concerning re-innervation mechanisms.  
In has been demonstrated that after denervation or nerve injury, muscle tissue 
undergoes transcriptional changes trying to induce re-innervation. The most 
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important defined signals are the over-expression of MuSK and AChR-ɣ subunit and 
also miR206 that promotes the expression of FGFBP1, leading to muscle re-
innervation (Williams et al., 2009). FGFBP1 is a secreted protein that interacts and 
potentiates the bioactivity of FGF-7, FGF-10, and FGF-22 family members (Jang and 
Van Remmen, 2011; Williams et al., 2009). 
At present the characterization of the mechanisms of muscle-nerve communication 
is an open issue. 
 
1.2 MUSCLE HYPERTROPHY AND ATROPHY 
 
Skeletal muscle mass is orchestrated by several complex mechanisms that regulate 
the rate of muscle growth and muscle loss. Muscle growth is mainly due to protein 
synthesis, that, when exceeds, leads to muscle hypertrophy. On the contrary, 
excessive protein degradation, loss of organelles and cytoplasm are major causes of 
muscle atrophy.  
 
Muscle Hypertrophy 
 
Skeletal muscle hypertrophy is defined as an increase in muscle mass, which in the 
adult animal comes as a result of an increase in the size of pre-existing skeletal 
muscle fibres. This growth, as stated above, is mainly due to increased protein 
synthesis and concomitant decreased protein degradation. The Insulin-like growth 
factor (IGF-1)-AKT signalling is the major pathway that controls muscle growth. 
Muscle-specific IGF-1 over-expression in transgenic mice results in muscle 
hypertrophy and, importantly, the growth of muscle mass matches with a 
physiological increase of muscle strength. Furthermore, the over-expression of a 
constitutively active form of AKT, a downstream target of IGF-1, in adult skeletal 
muscle induced muscle hypertrophy. Moreover, AKT transgenic mice display muscle 
hypertrophy and protection from denervation-induced atrophy, showing that AKT 
pathway promotes muscle growth and simultaneously blocks protein degradation 
(Schiaffino et al., 2013). AKT pathway, in fact, controls in an opposite manner two 
29 
 
important downstream targets: mammalian target of rapamycin (mTOR) and 
glycogen synthase kinase 3 beta (GSK3β). In the first case, AKT activates mTOR, that 
is a key regulator of cell growth, promoting the activation of S6 kinase (S6K) and 
blocking the inhibition of eif4e binding protein 1 (4EBP1) on eukaryotic translation 
initiation factor 4E (eif4e), thus leading to protein synthesis. In the other case, the 
inhibition of GSK3β from AKT stimulates proteins synthesis, since GSK3β normally 
blocks protein translation initiated by eIF2B protein (Glass, 2005). Taken together 
with other observations, these results suggest that IGF-1- AKT axis is a major 
mediator of skeletal muscle hypertrophy. Recently, it has been reported that also 
TGF-β pathway contributes to regulation of muscle mass in adulthood (Sartori et al., 
2013). Sartori et al. showed that when the BMP pathway is blocked or myostatin 
expression is increased, more Smad4 is available for phosphorylated Smad2/3, 
leading to an atrophy response. Therefore, under normal circumstances, a balance 
between these competing pathways is required to maintain muscle mass. Moreover 
they identify a newly characterized ubiquitin-ligase, named MUSA1, as the molecular 
mechanism underlying the anti-atrophic action of the BMP pathway that has a 
negative effect on its expression. This work provided evidences that also BMP 
signalling is involved in the regulation of adult muscle mass in normal and 
pathological situations (Sartori et al., 2013). 
 
Muscle atrophy 
 
Atrophy is defined as a decrease in cell size mainly due to protein degradation and 
then to the loss of organelles and cytoplasm as well. This is because protein turnover 
is dominant over cellular one during acute phases of muscle wasting, for example 
when sarcomeric proteins are rapidly lost during fasting, disuse, and denervation.  
Muscle loss is mediated by two highly conserved pathways: ubiquitin-proteasomal 
system (UPS) and autophagy-lisosomal pathway (ALP).  
Several evidences strongly support a major role of UPS during muscle loss. In this 
process Ubiquitin (Ub) is covalently attached to substrate proteins via a three-step 
mechanism involving the sequential actions of E1 (ubiquitin-activating enzyme), E2 
(ubiquitin-conjugating enzyme) and E3 (ubiquitin ligase) enzymes. The rate limiting 
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enzyme of UPS is the E3 which catalyzes the transfer of ubiquitin from the E2 to the 
lysine in the substrate. This reaction is highly specific and the proteins, committed to 
ubiquitination and to proteasomal degradation, are recognized by the E3. Thus the 
amount and the type of proteins degraded by the proteasome is largely determined 
by which E3 ligases are activated in the cell (Gomes et al., 2001). 
FoxO3 transcription is the key regulator of these systems, being it necessary and 
sufficient for the induction of autophagy in skeletal muscle in vivo (Mammucari et al., 
2007; Zhao et al., 2007). Moreover it induces the transcription of two fundamental 
muscles ubiquitin-ligases: Atrogin-1 and MuRF-1 (Sandri et al., 2004; Gomes et al., 
2001; Bodine, 2001). These ubiquitin-ligases were identified through gene 
expression profile analysis performed on different atrophic models, as part of a set 
of genes, called ‘atrogenes’, that triggered or were involved in the atrophic program. 
These genes encode for proteins involved in different cellular processes like energy 
production, transcription factors, regulators or protein synthesis and enzymes of 
metabolic pathways. Among the upregulated atrophy-related genes there is a subset 
of transcripts related to protein degradation pathways.  
Together these findings indicate that muscle atrophy is a process that requires the 
activation of a specific transcriptional program.  
 
1.3 AGEING IN MUSCLE TISSUE: SARCOPENIA 
 
During ageing muscle undergoes an inevitable loss of muscle mass accompanied by 
loss of force, that is called sarcopenia. It has been estimated that 25% of people 
under the age of 70, and 40% of people aged 80 or older are sarcopenic. As people 
age, the strength in their muscles gradually decreases at a rate of 1-2% per year 
after the age of 50 and by 30-40% at the age of 70 (Rossi et al. 2008). This condition 
profoundly contributes to a reduced quality of life in elderly and predisposes them 
to an increased risk of morbidity, disability and mortality (Visser and Schaap, 2011). 
Despite the clinical, social and economic relevance of sarcopenia, the precise 
mechanisms for the age-related loss of muscle mass and function are not yet fully 
understood. Age-related changes in muscle are complex with key features including 
myofibre atrophy, profound weakness that is partially independent from muscle 
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mass loss, myofibre degeneration, accumulation of dysfunctional mitochondria and 
increased oxidative stress.  
 
Until recently, it was thought that age-associated atrophy and weakness were 
secondary to motor-neuron loss in the brain or in spinal cord. However this 
hypothesis has been recently challenged. In fact little neuronal death occurs in most 
areas of ageing nervous system and there is no decline of lower motor neurons 
during ageing (Chai et al., 2011; Morrison and Hof, 1997). Conversely, it is emerging 
that the neuromuscular junctions (NMJ) and their interactions with myofibres are 
greatly altered during ageing, resulting in a loss of muscle innervation (Chai et al., 
2011; Valdez et al., 2010). In particular, loss of nerve endings has been reported at 
motor endplates in both rodents and humans, indeed in the soleus muscle of aged 
(22-month old) rats, both pre- and post-synaptic specializations were significantly 
smaller compared to that of the young (8-month old) rats (Deschenes and Wilson, 
2003). In this way, the muscle fibre seems to have an important role in the 
degeneration of motoneuron. It has been shown that reorganization of AChR plaque 
into multiple fragments was an occasional event that followed the degeneration of 
the underlying muscle fibre. Moreover, the increased prevalence of fragmented 
endplates in elderly was attributed to an increased incidence of sporadic muscle 
fibre degeneration events as the animal grew older (Li et al., 2011).  
 
Skeletal muscle tissue is particularly vulnerable to oxidative stress, in fact being a 
post mitotic tissue, it uses large amount of oxygen, thus causing cumulative 
oxidative damage to the cell structures over time. Sarcopenic muscle degeneration is 
associated to an age-related oxidative stress that leads to increased mitochondrial 
DNA damage, lipid peroxidation and protein oxidation. A great number of studies 
have shown an increase in oxidized proteins at the intracellular level during 
senescence, this causes loss of function in the affected protein that could lead to 
their accumulation, compromising organ functionality (Rossi et al., 2008). Oxidative 
stress and decreased release of trophic factors are considered two independent and 
important causes that affect NMJ integrity and contribute to denervation, also 
during ageing process (Jang and Van Remmen, 2011). Several laboratories have 
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tested the impact of oxidative stress on age-related muscle wasting. In order to 
elucidate the direct cause and effect relation between oxidative stress and 
sarcopenia in vivo, a mouse holding homozygous deletion of an essential antioxidant 
enzyme Sod1 (Cu/Zn superoxide dismutase, Cu/Zn SOD) was generated (Jang et al., 
2010). It has been shown that the lack of Sod1 led to age-dependent muscle atrophy 
with alterations in NMJs, that were similar to normal ageing muscle but occurred 
earlier and more frequently (Jang et al., 2010). These data indicated that 
maintenance of NMJ during ageing may be critically influenced by oxidative stress. 
For this reason it has been investigated whether mitochondrial dysfunction in the 
population of mitochondria associated with the NMJ may lead to altered calcium 
buffering and oxidative modification of key molecules in the NMJ, thus contributing 
to age-associated declines in neuromuscular innervation. Zhou et al. demonstrated 
that mitochondria adjacent to the AChR are selectively depolarized when muscle 
fibres are challenged by calcium in a mouse model of ALS, which exhibits significant 
neuromuscular degeneration (Zhou et al., 2010). In addition, other works have 
shown that muscle-specific over-expression of uncoupling proteins (UCP1) 
significantly disrupted NMJ integrity. Furthermore, it has been previously reported 
that isolated subsarcolemmal mitochondria of Sod1-/- mice have significant deficits 
in ATP generation and oxygen consumption, and also generate more mitochondrial 
ROS compared to wild-type (Jang et al., 2010). 
 
The exchange of trophic factors is implicated in pre- and post- synaptic development 
as well as in the preservation of neuronal and synaptic plasticity at the NMJ. The 
exact role or the identity of neurotrophic and/or myotrophic factors that promote 
survival and maintenance of pre-synaptic and post-synaptic apparatus at the NMJ, in 
the context of ageing, has not been fully determined. However, recent studies 
indicate that a variety of trophic factors such as brain derived neurotrophic factor 
(BDNF), neutrophin-3 (NT-3), neutrophin-4 (NT-4), cytokines such as glial-derived 
neutrophic factor (GDNF) and ciliary neutrophin factor (CNTF), and other growth 
factors as insulin-like growth factor (IGF-1 and IGF-II) and fibroblast growth factors 
(FGF), play a modulatory role in neuromuscular system to a different extent during 
ageing (Jang and Van Remmen, 2011).  
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Up to now it is not known whether myofibre denervation is due to deleterious 
changes, such as impaired trophic factors production or increased oxidative stress, 
in muscle cells themselves, in neurons or both components.  
 
Notably, two lifestyle adaptations, namely caloric restriction and exercise, have been 
consistently demonstrated to extend lifespan and, in parallel, to mitigate age-related 
alterations of NMJ (Melov et al., 2007; Fontana et al., 2010; Sandri et al., 2013; 
Schiaffino et al., 2013; Coen et al., 2013; Toledo et al., 2013; Guarente, 2013).  
It has been shown that caloric restriction directly attenuates age-related loss of 
muscle mass by improving mitochondria function, which in turn, lowers the 
mitochondrial ROS production in Sod-/- mice. Those effects of caloric restriction on 
mitochondria contribute to the preservation of NMJ morphology, innervation of 
muscle fibres, and maintenance of muscle mass and structure, improving also the 
regenerative potential of skeletal muscle, that normally decrease with age (Jang et 
al., 2012). 
Physical activity is known to trigger several changing in the muscle tissue such as 
switching of fibre type, increase in mitochondrial biogenesis, metabolic variation in 
glucose consumption and lactate production, activation of AMPK. AMPK is the AMP-
activated protein kinase that plays an important role in cellular energy homeostasis. 
In fact it is involved in many different pathways and is considered the master sensor 
of energy imbalance, as the major regulator of metabolic switch upon stress 
condition. When activated, it phosphorylates its direct target, acetyl-CoA carboxilase 
(ACC) and contributes to translocation of the glucose transporter Glut 4 on the cell 
surface (Kurth-Kraczek et al., 1999). Glut 4 is a muscle specific isoform of glucose 
transporter, and it is normally located in intracellular storage sites, and move to the 
cell surface in response to insulin, muscle contraction, and other stimuli that 
requires an increased glucose transport (Holloszy, 2011).  
Physical activity also triggers some beneficial effects on NMJ maintenance. Exercise 
in fact could partially reverse NMJ structural alterations that had already occurred 
after a denervation event (Valdez et al., 2010). Moreover since beneficial effects 
were observed in exercised muscles only, the ameliorated phenotype of the synapse 
resulted from local muscle-nerve interactions, suggesting that increased activity in 
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exercising muscles could lead to an up-regulation of trophic factors from muscle that 
would, in turn, improve synaptic maintenance (Valdez et al., 2010). These findings 
correlate with another work by Cheng (Cheng et al., 2013), where 21 months old 
mice and 18 months old mice, with reduced nerve terminal size, performed 
respectively 4 and 10 months voluntary wheel running. The authors found that after 
exercise most of the age-associated loss of nerve terminal area was prevented 
(Cheng et al., 2013). Furthermore, the positive effects of exercise are not limited to 
NMJ, but can be extended to a more general action to prevent ageing. In fact, 5 
months of exercise training were sufficient to completely reverse the premature 
ageing phenotype of the mitochondrial DNA mutator mice, which possess a 
dysfunctional copy of the mitochondrial proofreading-exonuclease, polymerase 
gamma (Safdar et al., 2011). 
It is important to consider another aspect that occurs during physical activity: 
contractions produce free radicals and ROS production is potentially damaging to 
the muscle tissues (Powers and Jackson, 2008). 
Several studies tried to identify ROS sources during exercise and a number of 
researchers have assumed that the increased ROS generation that occurs during 
contractile activity is directly related to the elevated oxygen consumption that 
occurs with increased mitochondrial activity (Kanter et al., 1994; Urso et al., 2003). 
Although mitochondria are involved in ROS production upon exercise, other studies 
pointed out that they are not the only source of ROS in skeletal muscle during 
exercise. Several works found NADH-oxidase enzyme associated with the 
sarcoplasmic reticulum (SR) of both cardiac and skeletal muscle, and it was 
responsible for the superoxide production. Thus, in this case, the superoxide 
generation influenced calcium release by the SR through oxidation of the ryanodyne 
receptor (Cherednichenko et al., 2004; Xia et al., 2003).  
Some recent findings proposed a new essential role for exercise-induced ROS 
formation, in promoting insulin sensitivity in humans, supporting the notion that 
anti-oxidants are detrimental for exercise-induced benefits in humans, although the 
mechanisms remain unclear (Ristow et al., 2011).  
Even it has been widely investigated the role of ROS during exercise is still not 
completely clear. 
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1.4 THE AUTOPHAGY-LYSOSOMAL SYSTEM 
 
The autophagy-lysosomal pathway is an evolutionarily conserved catabolic process 
essential for metabolic homeostasis maintenance, depending on nutrient 
availability. This process is responsible for the degradation of cytosolic component, 
long-lived proteins, damaged organelles, protein aggregates and intracellular 
pathogens. Autophagy in fact takes place at basal levels in all eukaryotic cells to 
maintain or rejuvenate function of proteins and organelles, but can also be induced 
by limitation of various types of nutrients, such as amino acids, growth factors, 
oxygen and energy as an adaptive mechanism essential for cell survival (Mizushima, 
2011). During the autophagy process, the cargo that needs to be degraded is 
engulfed by double membranes layer called autophagosomes. These membranes 
have to be committed, and this requires the recruitment of ATGs proteins on the 
membrane, as I will explain hereafter. Then the vesicles are delivered to the 
lysosomes where the cargo is degraded to amino acids that supply energy 
requirement. This role in recycling is complementary to that of the ubiquitin-
proteasome system, which degrades proteins to generate oligopeptides that are 
subsequently degraded into amino acids (Lecker et al., 2006). 
The autophagy system is highly regulated through the action of various kinases, 
phosphatases, and guanosine triphosphatases (GTPases). The core protein 
machinery that is necessary to commit membranes to become vesicles includes two 
ubiquitin-like protein conjugation systems (Sandri, 2010). Moreover there is 
another set of proteins, that regulates the vesicle formation and their docking and 
fusion with lysosome (Boya et al., 2013). 
There are mainly three classes of autophagy: macroautophagy, microautophagy, and 
chaperone-mediated autophagy (Figure 9).  
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Macroautophagy 
Macroautophagy uses the intermediate organelle ‘‘autophagosome.’’ An isolation 
membrane (also termed phagophore) sequesters a small portion of the cytoplasm, 
including soluble materials and organelles, to form the autophagosome. The 
autophagosome fuses with the lysosome to become an autolysosome that degrades 
the material within. This process appears to be selective in targeting to degradation 
specific organelles such as: mitochondria (mitophagy), portions of nucleus 
(nucleophagy), peroxisomes (pexophagy), endoplasmic reticulum (reticulophagy), 
microorganisms (xenophagy), ribosomes (ribophagy) and protein aggregates 
(aggrephagy) (Figure 9a).  
 
 
 
Fig.9: Scheme of the different type of autophagy: macroautophagy (a), microautophagy (b), 
chaperone-mediated autophagy (c) (Cuervo, 2011).  
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Microautophagy 
In microautophagy, the lysosome itself engulfs small components of the cytoplasm 
by inward invagination of the lysosomal membrane. Membrane dynamics during 
microautophagy may be quite similar or identical to that of endosomal sorting 
complex required for transport (ESCRT)-dependent multivesicular body (MVB) 
formation, which occurs in the late endosome (Figure 9b).  
 
Chaperone-Mediated Autophagy (CMA) 
The third type of autophagy is chaperone-mediated autophagy (CMA). This class 
does not involve membrane reorganization; instead, substrate proteins directly 
translocate across the lysosomal membrane. The chaperone protein Hsc70 (heat 
shock cognate 70) and co-chaperones specifically recognize cytosolic proteins that 
contain a KFERQ-like pentapeptide. The transmembrane protein Lamp-2A, which is 
an isoform of Lamp-2, acts as a receptor on the lysosome, and unfolded proteins are 
delivered into the lysosomal lumen through a multimeric translocation complex 
(Mizushima, 2011) (Figure 9c). 
 
Macroautophagy, hereafter called autophagy, is thought to be the major type of 
autophagy, and it has been studied most extensively compared to microautophagy 
and CMA.  
Autophagy is activated by both caloric restriction and exercise (Grumati et al., 2010; 
Grumati et al., 2011a; Grumati et al., 2011b; He et al., 2012; Rubinsztein et al., 2011; 
Wohlgemuth et al., 2010).  
Although many studies focused on these topic the mechanism that link autophagy to 
these lifestyle conditions is still under investigation. 
 
1.4.1 The autophagy genes 
 
Genetic screens in S. cerevisiae have led to the identification of a number of 
molecular factors essential for autophagy. There are currently over 30 genes that 
are primarily involved in bulk and selective types of autophagy and they have been 
named autophagy-related genes (ATG) (Klionsky et al., 2003). ATGs encode for 
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proteins that mediate the autophagic process; in particular they orchestrate the 
following steps: initiation, elongation, maturation and fusion of the autophagosome 
with the lysosome, and cargo degradation (Tan, 2013) (Table 1). 
 
 
 
Table 1: ATG proteins. The 15 conserved autophagy-related gene (Atg) proteins involved in 
double-membrane vesicle formation (adapted from Tan, 2013). In the left column are reported 
the mammalian proteins, while on the right the homologue ones in yeast.  
 
1.4.2 Autophagy Machinery 
 
Traditionally, it has been believed that autophagosome formation starts at 
phagophore assembly sites. Phagophore is an autophagosome precursor and its 
formation requires the class III phosphoinositide 3-kinase (PI3K) Vps34, which acts 
in a large macromolecular complex that also contains Atg6 (also called BECLIN1), 
Atg14, and Vps15 (p150) (Figure 10). Other proteins involved in the early stages of 
autophagy include Atg5, Atg12, Atg16, focal adhesion kinase (FAK) family-
interacting protein of 200 kD (FIP200), which interacts with Atg1 (also called 
ULK1), and the mammalian ortholog of Atg13.  
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Fig.10: Possible origins for the membrane of the nascent autophagosome. This image reports 
the major players involved in the autophagosome formation (Rubinsztein et al., 2011). 
 
The elongation of the autophagosomal membranes is a critical step that is associated 
with two ubiquitination-like reactions. In the first one, Atg12 is conjugated to Atg5 
by Atg7, which is an E1 ubiquitin-like activating enzyme, and Atg10, which is an E2 
ubiquitin-like conjugating enzyme. The Atg5-Atg12 conjugates interact non 
covalently with Atg16L1 and the whole complex associates with growing 
phagophores but dissociates once the autophagosomes is complete (and so the 
membrane is closed). In the second ubiquitin-like reaction, microtubule-associated 
protein 1 light chain 3 (MAP-LC3/Atg8/LC3) is conjugated to the lipid 
phosphatidylethanolamine (PE) with a covalent bond, by Atg7 (E1-like) and Atg3 
(E2- like) to form LC3-II (Figure 11) (Rubinsztein et al., 2011). This modification 
results in a change of the molecular weight of LC3 that allows to distinguish by 
western blot the cytoplasmic soluble LC3-I, from the lipidated LC3-II isoforms. 
Usually, the accumulation of LC3-I or a decrease in LC3II means that autophagy is 
blocked. 
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Fig.11: Ubiquitination-like reactions in the autophagosome formation: Atg12-Atg5 conjugation 
system and LC3 lipidation process (adapted from Kroemer et al., 2010). 
 
LC3-II is required both on the outer and inner membranes of the nascent 
autophagosome. Sequestered organelles and proteins are then docked to the 
lysosomes for their degradation. The fusion between the outer autophagosomal 
membrane with the lysosomal one also determines the degradation of the inner 
membrane and of the proteins that are associated with it. Because of the transient 
nature of the autophagosomes, the lifetime of LC3 and its homologues is rather 
short. This feature represents the main difference between the ubiquitin-
proteasome system and the autophagy-lysosome one, in fact the fate of the ubiquitin 
and ubiquitin-like proteins is different. While the ubiquitin proteasome pathway 
recycles ubiquitin molecules, the autophagy-lysosome system progressively loses 
the ubiquitin-like proteins, forcing the cell to replenish them in order to maintain 
the autophagic flux. Multiple LC3-positive autophagosomes form randomly in the 
cytoplasm, then they are trafficked along microtubules in a dynein-dependent 
manner to lysosomes, which cluster close to the microtubule organizing center 
(MTOC) near the nucleus. Autophagosome-lysosome fusion appears to be mediated 
by the SNARE proteins VAMP8 and Vti1B (Rubinsztein et al., 2011).  
Selective autophagy relies on cargo-specific autophagy receptors that facilitate cargo 
sequestration into autophagosomes. Autophagy receptors directly interact with the 
structure that needs to be specifically eliminated by autophagy, as well as with the 
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pool of the Atg8 (yeast homologue of mammalian LC3) protein family members 
present in the internal surface of the growing autophagosomes. The latter 
interaction is mostly mediated through a specific amino acid sequence present in the 
autophagy receptors and commonly referred to as the LC3-interacting region (LIR) 
or the Atg8-interacting (AIM) motif (Figure 12). One of the most important and well 
known ubiquitin-associated protein that provides a link between autophagy and 
selective protein degradation is p62, also called sequestosome 1 (SQSTM1)(but 
hereafter referred as p62). 
 
 
Fig.12: Cargo-specific autophagy receptors structure, here are reported the two receptors p62 
and NBR1, with the main structural and interacting domain (adapted from Johansen and 
Lamark, 2011). 
 
This protein is characterized by several different domains that account for its 
different functions. In particular it has been showed the presence of an N-terminal 
Phox and Bem1 (PB1), a zinc finger domain (ZZ) and a TRAF-6 binding domain (TB), 
moreover p62 contains LIR domain, and the C-terminal ubiquitin-associated (UBA). 
p62, in fact, can bind a large number of proteins through its multiple protein–
protein interaction motifs. Structural analysis reveals that PB1 domain exhibits self-
oligomerization, that allows the binding of different molecules, such as NBR1, that is 
an autophagic cargo receptor with structural similarities with p62, and it is 
selectively degraded by autophagy too (Johansen and Lamark, 2011). Zinc finger 
domain (ZZ) and TRAF-6 binding domain (TB) are important because p62 functions 
as scaffold protein for several signal transductions, and so these domain allow the 
interaction between p62 with various signalling proteins such as RIP, TRAF6, ERK, 
PKC, and caspase-8. For these reason p62 is involved in very different molecular 
pathways. As I reported before, p62 contains LIR domain, as LC3 interacting domain, 
and the C-terminal ubiquitin-associated (UBA) domain that can bind ubiquitinated 
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proteins. Recent studies have identified the LC3 recognition sequence (LRS) in 
murine p62, that is located between the zinc finger and UBA domains and has the 
same function of LIR in the human one. In this way p62 acts as a bridge between 
ubiquitinated proteins that has to be degraded and LC3-II located in the inner 
membrane of the autophagosome. Since LC3-II in the inner autophagosomal 
membrane is degraded together with other cellular constituents by lysosomal 
proteases, p62 trapped by LC3 is transported selectively into the autophagosome, 
and the impaired autophagy is accompanied by accumulation of p62 (Ichimura and 
Komatsu 2010). p62 is more linked to the autophagy-lysosome system than to the 
ubiquitin-proteasome system. In fact inhibition of lysosomal degradation but not 
proteasomal one, results in important accumulation of p62 (Bjørkøy et al., 2005; 
Pankiv et al., 2007). Accumulation of p62 results in self-oligomerization and 
formation of aggregates that contain polyubiquitinated proteins. Moreover, tissue 
specific inhibition of autophagy leads to a rapid and robust increase in p62 protein 
levels (Komatsu et al., 2007). There is crosstalk between different degradation 
pathways for misfolded proteins, indeed the loss of one degradation system may 
result in the activation of other systems. However, a high constitutive level of p62 
caused by autophagy inhibition may itself contribute to an increased formation or 
decreased degradation of Ub-proteins. It is suggested that p62 accumulation due to 
autophagy inhibition delays the delivery of ubiquitinated proteins to the 
proteasome (Johanse and Lamark, 2011). p62 is also required in the targeting to the 
autophagosomes of dysfunctional mytochondria, thus being involved in the specific 
selective autophagy process, called mitophagy. 
 
1.4.3 Mitophagy  
 
Mitochondria are crucial organelles in the production of energy and in the control of 
signalling cascades. Moreover mitochondria are dynamic organelles, often organized 
in the cytoplasm as a network, a reticulum of interconnected organelles shaped by 
fusion (joining individual mitochondria together to become one) and fission 
(dividing one mitochondrion into two mitochondria) processes. When either 
process is blocked, the unopposed progression towards the other side of the 
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equilibrium defines how mitochondria appear. In mammalian cells, mitochondrial 
fission depends on dynamin-related protein 1 (DRP1), and FIS1, on the contrary 
fusion process depends on two mitofusins (Mfn1 and Mfn2) and the protein optic 
atrophy 1 (OPA1) (Scorrano, 2013; Hall et al., 2013). Several studies demonstrated 
that mitochondria shaping machinery is involved in the response of essential 
changes in the cell (Romanello et al., 2010; Gomes et al., 2011).  
Since mitochondria are fundamental and required for several physiological 
pathways, a well defined mitochondria control and turnover is essential for cell 
homeostasis. Moreover, cells must remove damaged mitochondria to prevent the 
accumulation of ROS. The control of mitochondrial quality is mediated by 
mitophagy, a specific type of macroautophagy, that is very important in preventing 
ageing, neurodegenerative diseases, and other pathologies. In response to 
potentially lethal stress or damage, mitochondrial membranes undergo 
permeabilization (MMP), that constitutes one of the hallmarks of imminent 
apoptotic or necrotic cell death (Kroemer et al., 2007). If only a fraction of 
mitochondria is permeabilized, autophagic removal of damaged mitochondria can 
rescue the cell.  
 
 
 
Fig.13: Mitochondrial recruitment during mitophagy: (A) Atg32 in yeast, NIX and BNIP in 
mammals bind mitochondria that has to be degraded, (B) moreover mitophagy can be 
stimulated by mitochondrial fission through DRP1 activation (adatpted Dodson et al., 2013). 
 
The integrity of mitochondrial membrane is essential for the maintenance of the 
mitochondrial membrane potential, for this reason when the mitochondrial 
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membrane is permeabilized, mitochondria are not able to maintain the potential 
anymore, becoming depolarized. 
The autophagic recognition of depolarized mitochondria is mediated by a voltage 
sensor, involving the mitochondrial kinase PINK1. Under normal condition, PINK1 is 
continuously recruited to the mitochondrial outer membrane and degraded through 
a voltage-dependent proteolysis, which leads to its removal from mitochondria first, 
and to proteasome-mediated degradation later (Narendra et al., 2010). Upon 
mitochondrial depolarization, PINK1 rapidly accumulates on the mitochondrial 
surface, and facilitates the recruitment of the E3 ubiquitin ligase PARKIN (Narendra 
et al., 2010). PARKIN ubiquitinates mitochondrial substrates including the outer 
membrane protein VDAC1 and Mitofusin (Mfn), recruits the autophagy adaptor 
molecule, p62/SQSTM1, and thus targets mitochondria for autophagic removal 
(Geisler et al., 2010). Mitophagy can be mediated by specific factors, such as Atg32 in 
yeast, NIX and BNIP in mammals, that target to mitochondria and bind to LC3 
(Figure 13A); it can also be stimulated by mitochondrial fission through DRP1 
activation. (Dodson et al., 2013; Lee et al., 2012)(Figure 13B). 
 
1.4.4 Molecular signalling in autophagy  
 
Autophagy is induced by a variety of stress stimuli, including nutrient and energy 
stress, ER stress, pathogen-associated molecular patterns (PAMPs) and danger-
associated molecular patterns (DAMPs), hypoxia, oxidative stress, and 
mitochondrial damage. This signals triggers not only autophagy activation, but also 
several changes involved in cellular stress response. 
Autophagy is mainly regulated by nutrient availability, so the insulin pathway is the 
major player in autophagy regulation. In condition of nutrient deprivation, in fact 
autophagy is activated. The best characterized regulator of autophagy is mTOR 
kinase that is responsible for several processes (Figure 14). It takes part to two 
different complexes, mTORC1 and mTORC2, that differs for the regulatory proteins, 
Raptor and Rictor, respectively. Moreover only mTORC1 is inhibited by Rapamycin. 
mTORC1 is the most involved in autophagy control. This kinase negatively regulates 
autophagy by inhibiting the activity of the Atg1 (ULK1) complex through directly 
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phosphorylating it. mTORC1 is stimulated by availability of nutrient, amino acids 
and growth factors, while it is inhibited when amino acids are scarce, growth factor 
signalling is reduced and/or ATP concentrations fall, thus resulting in de-repression 
of autophagy. In mammalian cells, ULK1 can also be directly phosphorylated by 
AMP-activated protein kinase (AMPK) in response to energy imbalance. Thus AMPK 
triggers autophagy by both positively regulating the Atg1(ULK1) complex and 
inhibiting mTOR. 
 
 
Fig.14: mTORC1-dependent signalling pathways (Dodson et al., 2013). 
 
The phosphatidylinositol-3-OH kinase (PI(3)K) complex I is also a major point of 
regulation for the kinases that modulate autophagy induction. This complex 
contains phosphatidylinositol-3-OH kinase (PI(3)K) also called Vps34, that is the 
only PI3K expressed in eukaryotic cells, Beclin-1 (a mammalian homolog of yeast 
Atg6), p150 (a mammalian homolog of yeast Vps15), and Atg14-like protein (Atg14L 
or Barkor) or ultraviolet irradiation resistance-associated gene (UVRAG), and is 
required for the induction of autophagy. Beclin-1 is one of the subunits of the PI(3)K 
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complex I and its incorporation into this complex, which is essential to stimulate 
PtdIns3P synthesis, is dependent on other proteins, such as Bcl-2, 14-3-3 or the 
intermediate filament protein vimentin 1 (VMP1). The phosphorylation of BECLIN1 
by the death-associated protein kinase (DAPK) or phosphorylation of Bcl-2 by the c-
Jun N-terminal kinase (JNK) triggers the dissociation of the Beclin-1–Bcl-2 complex 
allowing Beclin-1 to associate with the PI(3)K complex I.  
Furthermore, AMPK, stimulates autophagy in response to glucose starvation by 
phosphorylating BECLIN1 on a different residue that of the inhibitory kinases, and 
promotes its incorporation into the PI(3)K complex I (Boya et al 2013). In this 
condition, in fact, autophagy is up-regulated as compensation for the loss of key 
metabolites, whereas loss of autophagy or excessive autophagy may be detrimental 
to the cell (Dodson et al., 2013). 
 
Some of the other regulatory molecules that induce autophagy are the eukaryotic 
initiation factor 2α (eIF2α), which responds to nutrient starvation, double-stranded 
RNA, and unfolded protein response (UPR), the major ER stress pathway 
(Buchberger et al., 2010; Kouroku et al., 2007). 
 
Furthermore, mitochondria detain an important role in autophagy regulation. I have 
already reported that mitophagy is activated upon mitochondria damage. It is also 
well known that damaged mitochondria produce ROS thus increasing cell oxidative 
stress.  
Oxidative stress reflects an imbalanced condition between reactive oxygen species 
(ROS) production and the capability of the cell to buffer or eliminate these 
molecules. In fact, ROS are formed by the incomplete reduction of oxygen and are 
produced at low levels under normal physiological condition as a result of 
mitochondria respiration and a number of other processes. The cell is able to cover 
this production through several antioxidant defences. When these systems are 
overloaded oxidative stress occurs and leads ultimately to cell death. Oxidative 
stress is responsible for DNA mutations, and damage of cellular components such as 
lipids and proteins; in particular it can lead to the non-specific post-translational 
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modifications of proteins, named carbonylation, and contributes to protein 
aggregation (Underwood et al.,2010; Rossi et al., 2008; Lee et al., 2012). 
Oxidative stress has been demonstrated across several tissue types to play an 
important role in control of autophagy, ageing and in the progression of a multitude 
of diseases including neurodegeneration, cardiovascular diseases, and cancer (Lee et 
al. 2012). A general concept is that oxidative stress induces autophagy to remove 
oxidized protein (Dodson et al., 2013) and dysfunctional organelles (Figure 15). 
Furthermore, it has been demonstrated that anti-oxidant treatment is able to 
prevent or rescue protein oxidation (Whidden et al., 2010; Desaphy et al., 2010), but 
other studies pointed out its effect on autophagy. A recent work showed that both 
thiol antioxidants, in particular N-acetil-cysteine (NAC), and non-thiol antioxidants, 
profoundly impair both basal and induced autophagy, through different signalling 
pathways (Underwood et al., 2010). In fact, although thiol antioxidants inhibit 
mTOR, they also reduce the phosphorilation levels of JNK and BCL-2, reducing the 
availability of BECLIN1, that is required for autophagosome formation, thus 
resulting in autophagy impairment. On the contrary, non-thiol antioxidants activates 
mTOR, that consequently sequesters ULK-1 from autophagy pathway (Underwood 
et al., 2010).  These findings suggest that basal level of oxidative stress is an 
important signal that mediates autophagy activation thus maintaining tissue 
homeostasis, because depletion of ‘physiological ROS’ in healthy cells leads to 
impaired autophagy and homeostatic imbalance.  
 
Oxidative stress can also induce autophagy, through p53 activation. This is a very 
open topic, since there are opposite evidence regarding the role of p53, but what is 
known is that p53 is a tumor suppressor protein that has a dual effect on autophagy, 
acting both as a positive and negative regulator.  
It was demonstrated that p53 induces autophagy via its transcriptional activity and 
acts as a negative regulator of autophagy via its cytoplasmic functions (Green and 
Kroemer, 2009). On the contrary, a recent work reported that cytosolic p53 leads to 
autophagy induction by activation of AMPK and mTOR suppression, and inhibit 
autophagy translocating to the nucleus and increasing transcription of TSC1, the 
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direct inhibitor of mTOR pathway (Dodson et al., 2013). So further works are 
required to clarify autophagy regulation by p53. 
Other stimuli are involved in autophagy regulation, for example oxygen rate. Both 
hypoxia and anoxia (with oxygen concentrations <3% and <0.1%, respectively) 
triggers autophagy through a variety of different mechanisms. Hypoxia-induced 
autophagy depends on hypoxia-inducible factor, HIF, while anoxia-induced 
autophagy is HIF independent (Majmundar et al., 2010; Mazure and Pouyssegur, 
2010).  
 
 
 
Fig.15: Representative scheme of some of the major player involved in autophagy regulation: 
oxidative stress, hypoxia and anoxia condition, p53, mitochondrial dysfunction (Kroemer et al., 
2010). 
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1.4.5 Autophagy in disease  
 
Autophagy occurs at basal levels in most tissues and contributes to the routine 
turnover of cytoplasmic components. In fact it is involved in development, 
differentiation, and tissue remodelling in various organisms. In contrast, a dramatic 
enhancement of autophagy can be triggered by some conditions such as starvation 
and hormonal stimulation as a defensive mechanism (Levine and Klionsky et al., 
2004). Autophagy is also implicated in wide range of diverse human diseases. In 
cancer autophagy mainly acts as tumor suppressor, while clearing aggregate-prone 
mutant proteins in several neurodegenerative diseases. These include proteins with 
polyglutamine (polyQ) of Huntington’s disease and spinocerebellar ataxia, mutant α-
synucleins of Parkinson syndrome, and mutated tau aggregation in fronto-temporal 
dementia (Williams et al., 2006). Autophagy is plays a role also in muscular 
disorders, such as Pompe and Danon disease and X-linked myopathy, liver diseases 
and pathogen infection (Levine and Kroemer, 2008). 
 
1.5 AUTOPHAGY AND MUSCLE  
1.5.1 Regulation of autophagy in skeletal muscle 
Autophagy is constitutively active in skeletal muscle. It is essential for proper 
muscle homeostasis, in fact it is required to maintain muscle mass (Masiero et al., 
2009) and is a mechanism of stress-response. Autophagy is induced in skeletal 
muscle in the immediate post-natal period when glycogen-filled autophagosomes 
are abundant (Schiaffino and Hanzlikova, 1972a). The crucial role of autophagy in 
the newborn is demonstrated by the finding that mice deficient in autophagy genes 
Atg5 or Atg7 die soon after birth during the critical starvation period when 
transplacental nutrient supply is suddenly interrupted (Komatsu et al., 2005; Kuma 
et al., 2004).  
FoxO3 is the master regulator of autophagy in adult muscles (Mammucari et al., 
2007). Expression of FoxO3 is sufficient and required to activate lysosomal-
dependent protein breakdown in cell culture and in vivo. Moreover several 
50 
 
autophagy genes including LC3, Gabarap, Bnip3, VPS34, Atg12 are under FoxO3 
regulation. Gain and loss of function experiments identified BNIP3, a BH3-only 
protein, as a central player downstream of FoxO in muscle atrophy (Mammucari et 
al., 2007; Tracy et al., 2007). These studies allowed to identify the most potent 
autophagy inhibitor in skeletal muscles: AKT kinase. Acute activation of AKT in adult 
mice or in muscle cell cultures completely inhibits autophagosome formation and 
lysosomal-dependent protein degradation during fasting (Mammucari et al., 2007; 
Zhao et al., 2007; Zhao et al., 2008).  
A clear pathway as been identified in muscle. In presence of nutrients IGF1/Insulin 
signalling pathway is activated, this leads to the activation of AKT. When AKT is 
phosphorylated (P-AKT), it activates mTOR, thus increasing protein synthesis rate, 
and blocking autophagy; on the contrary, P-AKT phosphorylates FoxO, that in this 
way is sequestered in the cytosol, and its transcriptional action is blocked, leading to 
autophagy inhibition (Figure 16, left panel). During stress or pathological 
conditions, such as nutrient deprivation, diabetes, cachexia, AKT signal is blocked, 
and in addition mTOR negative regulation on autophagy is removed. In this way, 
FoxO can translocate into the nucleus, promoting transcription of several genes, in 
particular some autophagy genes such as Bnip3, LC3 and p62, leading to autophagy 
activation (Figure 16, right panel).  
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Fig.16: Regulation of autophagy in muscle tissue, in presence of IGF-1 and Insulin signals FoxO 
is phosphorylated by AKT and blocked outside the nucleus (on the left), during starvation or 
denervation AKT is not active, so FOXO can enter into the nucleus mediating transcription of 
the autophagy genes thus leading to autophagy activation.  
 
1.5.2 The in vivo model of muscle-specific block of autophagy   
 
During muscle denervation or muscle loss autophagy-lysosome system is severely 
induced (Sandri, 2008). 
 Electron microscopic studies previously showed that autophagy is activated in 
denervation atrophy (Schiaffino and Hanzlikova, 1972b) and the lysosomal 
proteolytic system is stimulated in different atrophic conditions, such as nutrient 
deprivation or disuse (Bechet et al., 2005). Furthermore among designated atrophy-
related genes or atrogenes, that are upregulated during muscle loss, several belong 
to the autophagy-lysosome system, in particular LC3 and Gabarap (Mammucari et 
al., 2007; Mammucari et al., 2008; Zhao et al., 2007). 
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After these results, it was still unclear whether activation of autophagy during 
muscle loss was detrimental, contributing to muscle degeneration or whether it was 
a compensatory mechanism for cell survival. So, in order to investigate the role of 
basal autophagy in muscle, in my laboratory were generated two knockout mice for 
the critical Atg7 gene to block autophagy specifically in skeletal muscle (Masiero et 
al., 2009). Atg7-floxed mice (Atg7f/f) were crossed with a transgenic line expressing 
Cre recombinase (CRE) under the control of a myosin light chain 1 fast promoter 
(MLC) to generate muscle-specific Atg7 knockout mice (Atg7-/-MLC), lacking 
autophagy process from birth (Figure 17A). Tamoxifen-inducible muscle-specific 
Atg7 knockout mice (Atg7-/-HSA) were also generated to evaluate the role of acute 
block of autophagy at different stages. In these mice Atg7 gene is deleted only after 
Tamoxifen treatment because Cre recombinase (CRE) fused with estrogen receptor 
(ER) is constantly degraded. Tamoxifen binds ER thus preventing CRE degradation 
and mediating its localization in the nucleus, where it triggers the deletion of Atg7 
only in skeletal muscle, because it is under the control of human skeletal actin 
promoter (HSA) (Figure 17B). 
 
 
 
Fig.17: Schematic representation of ATG7-/- MLC (A) and ATG7-/- HSA (B) mice generation. 
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Autophagy block was verified by the absence of the lipidated form of LC3 (LC3-II), as 
it is indicated in Figure 18 (upper panel). Moreover, since p62 is no more degraded, 
it accumulates in autophagy deficient mice, thus leading to self-oligomerization and 
formation of p62 aggregates (Figure 18, lower panel). 
 
 
 Fig.18: Block of autophagy prevents LC3 lipidation (upper panel) and induces p62 aggregates 
formation (lower panel). 
 
Surprisingly, suppression of autophagy was not beneficial and instead triggers 
atrophy, weakness and several myopathic features (Figure 19). Atg7-/- MLC and HSA 
mice shared the same features, indicating that both prolongued (conditional model) 
and acute (inducible model) block of autophagy are able to induce muscle loss. 
 
 
Fig.19: Myopathic phenotype observed in ATG7-/- MLC mice. H&E staining reveal the presence of 
atrophic and centernucleated myofibres in ATG7-/- MLC mice (Masiero et al., 2009).  
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Moreover deletion of Atg7 gene causes accumulation of abnormal mitochondria and 
of concentric membranous structures that assemble between the myofibrils or just 
beneath the sarcolemma, induction of oxidative stress and activation of unfolded 
protein response. Together, these pathological conditions lead to myofiber 
degeneration.  
These results indicate that autophagy is required for skeletal muscle mass 
maintenance and homeostasis. 
 
1.6 AUTOPHAGY AND AGEING 
 
Almost all ageing organisms share a gradual decrease in the activity of ubiquitin-
proteasome and autophagy. Numerous pieces of evidence indicate that autophagy 
declines with age and this progressive reduction might cause functional 
deterioration during ageing (Tan et al., 2013). Recent studies in human detected 
down-regulation of autophagy genes (ATG5 , ATG7 , and BECN1) in the brain of old 
persons compared with young ones (Lipinski et al., 2010). Although different studies 
have established a tight connection between autophagy and ageing, a one-way 
cause-and-effect relationship still remains obscure (Tan et al., 2013). In mammals, 
the relationship between autophagy inhibition and ageing is still widely 
phenomenological and correlative. Conversely, robust genetic evidences in worms 
and flies underline such connection. Indeed, deficient expression of Atg1, Atg7, Atg8, 
Beclin 1 and Sestrin1 (which is also required for basic autophagy) shortens the 
lifespan of the fruit fly Drosophila Melanogaster and of the worm C. Elegans (Lee et 
al., 2010b; Rubinsztein et al., 2011; Simonsen et al., 2008). This is linked to age 
associated pathologies that are mainly relevant in brain, skeletal and cardiac 
muscles (Lee et al., 2010b). On the other hand, increased autophagy contributes to 
longevity and mutation of essential ATG genes prevents this effect (Melendez et al., 
2003). Importantly, a recent report underlines that the ageing process can be 
controlled by a single tissue (Demontis and Perrimon, 2010). In fact over-expression 
of FoxO transcription factor or its target 4EBP1 in the skeletal muscles of flies 
abolishes the age-associated decline in autophagy and increases longevity while it 
reduces food intake and insulin release from neurosecretory cells. These data show 
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that maintenance of a normal autophagy level in skeletal muscle, but not in adipose 
tissue, positively affects whole-body metabolism (Demontis and Perrimon, 2010). 
FoxO3 is the a main regulator of autophagy (Mammucari et al., 2007; Mammucari et 
al., 2008; Zhao et al., 2007) and, interestingly, genetic variations in the human FoxO3 
have been linked to longevity in multiple population studies (Kenyon, 2010).  
As I reported before, sarcopenia can be defined as ageing of muscle tissue. In 
mammals the role of autophagy during sarcopenia is still controversial, because 
either impaired or excessive autophagy have been associated to it (Wenz et al., 
2009; Wohlgemuth et al., 2010). Among all the studies done, loss-of-function 
experiments that support the involvement of autophagy in ageing sarcopenia are 
still lacking. 
 
1.7 AUTOPHAGY AND EXERCISE 
 
As I reported before, physical exercise is an important lifestyle practice that induces 
a multitude of beneficial adaptations both in humans and rodents. Regular physical 
activity has been demonstrated to improve glucose and lipid homeostasis, maintain 
muscle mass and delay ageing (Melov et al., 2007; Fontana et al., 2010; Sandri et al., 
2013; Schiaffino et al., 2013; Coen et al., 2013; Toledo et al., 2013). Although the 
positive effects of exercise are undisputed, the underlying mechanisms are still 
under vigorous investigation, in particular the possible link with autophagy. 
Previous work revealed that an acute bout of exercise is sufficient to induce 
autophagy in skeletal muscle (Grumati et al., 2011). Others have further confirmed 
these findings reporting that physical activity-induced adaptations that may be 
mediated by the activation of autophagy (He et al., 2012; Kim et al., 2013).  
Mice with defective stress-induced autophagy, but proper basal autophagy, were 
found to run significantly less on a treadmill than the wild types (He et al., 2012). 
Moreover, these mice do not obtain the same exercise-mediated benefits and were 
not protected from high fat diet-induced glucose intolerance. This supports that 
exercise-induced metabolic rejuvenation occurs through the stimulation of 
autophagy. Moreover, He et al. identified AMPK as a potential player in the exercise-
induced autophagy-mediated metabolic improvements. In their hands, AMPK 
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activation presumably leads to the up-regulation of the glucose transporter, GLUT4, 
at the muscle membrane, thus increasing the capacity for muscular glucose uptake 
(He et al., 2012). However, the signalling cascade responsible has not been 
elucidated yet. These findings remain controversial as skeletal muscle–specific 
autophagy-knockout mice show the opposite phenotype. These mice appear to have 
an improved metabolic profile and increased sensitivity to insulin, that protects 
them from diet-induced obesity (Kim et al., 2013). These contrasting results may be 
due to the difference in tissue specific versus general autophagy disturbance and, 
therefore, highlight a potential cell autonomous regulation, which has yet to be 
investigated.  
In conclusion, it is still unknown whether it is whole body or muscle-specific 
autophagy that is required to sustain contraction, maintain glucose homeostasis, 
and trigger exercise-induced benefits. 
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1.8 AIM OF THE WORK 
 
It is widely accepted that autophagy declines with age and this progressive 
reduction might have a role in the functional degeneration of tissues, but a direct 
causative relationship still remains undefined. Moreover, the role of autophagy 
during ageing of muscle tissue, in mammals, is still controversial and loss-of-
function experiments that support its involvement are still lacking.  
In order to investigate the role of autophagy inhibition in skeletal muscle during 
ageing, we mimic that condition in vivo, through muscle-specific block of autophagy 
process.  
My work is focused on the characterization of muscle-specific aged autophagy 
knockout mice (Atg7-/-MLC).  
Moreover, since it is known that exercise has a beneficial effect on ageing features 
and moreover it is able to reactivate autophagy in elderly, we wanted to understand 
whether these beneficial effects are triggered by autophagy, and so indentify the 
role of autophagy during muscle contraction. It is known that autophagy is activated 
upon exercise, but the effects of this induction are still controversial. In fact, whether 
it is whole body or muscle specific autophagy that is required to sustain contraction, 
maintain glucose homeostasis, and triggers exercise-induced benefits, remains 
unknown. 
In order to clarify this issue, we used muscle-specific inducible autophagy deficient 
mice (Atg7-/-HSA), to minimize the chance of any adaptations and compensations 
that occur with constitutive deletion of genes. 
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2. MATERIALS AND METHODS 
 
2.1 GENERATION OF MUSCLE-SPECIFIC ATG7 KNOCKOUT 
MICE  
 
Muscle-specific Atg7-/- MLC and Atg7-/- HSA mice generation have been previously 
described by Masiero et al., 2009. Briefly Atg7 floxed mice Atg7f/f (Komatsu et al., 
2005) were crossed with transgenic mice expressing Cre-recombinase (CRE) under 
the control of a Myosin Light Chain 1 fast promoter (MLC-1f), that is expressed only 
in skeletal muscle during the embryonic development. In order to obtain inducible 
muscle specific Atg7 knockout mice, Atg7 floxed mice (Komatsu et al., 2005) (Atg7f/f) 
were crossed with transgenic mice expressing a Cre-recombinase fused with a 
modified estrogen receptor domain (Cre-ERTM) driven by Human Skeletal Actin 
promoter (HSA) (Schuler et al., 2005). In order to induce the deletion of Atg7 gene 
we treated animals with Tamoxifen food (Harlan) for 9 weeks. We characterized 
muscle-specific autophagy deficient (Atg7-/-) and control (Atg7f/f) mice. We analized 
adult (2, 5 and 10 months old) and aged (26 months old) mice.  
 
2.1.1 Genotyping of muscle specific Atg7 knockout mice  
Mice were identified by analyzing the presence of Cre-recombinase on genomic DNA 
by PCR .  
We used a lysis buffer containing Tris-HCL 1M pH 7.5 and Proteinase K 10mg/mL 
(Life Technologies). 
The samples were denaturated by incubation for 1 hour at 57°C and then the 
proteinase K was inactivated at 99°C for 5 minutes. For the PCR reaction we used 
the following primers and program: 
Primers: 
NSP-780: CACCAGCCAGCTATCAACTCG 
NSP-979: TTACATTGGTCCAGCCACCAG 
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We prepared a 20 μl total volume mix for each sample with:  
Template DNA: 2 μl 
Primer NSP-780 (10 μM): 0.2 μl  
Primer NSP-979 (10 μM): 0.2 μl 
GoTaq Green master mix 2X (Promega): 10 μl 
Water 
 
Program: 
step 1: 94° C for 3 minutes 
step 2: 94° C for 45 seconds 
step 3 61° C for 30 seconds 
step 4 72°C 1 minute 
step 5: go to step 2 for 40 times 
We detected Cre-recombinase DNA (200 bp) with a 2% agarose gel (Figure 1). 
 
 
Fig. 1: Representative image of eletrophoretic run of DNA, mice in which the deletion of Atg7 
occurred, resulted Cre positive. 
 
2.2 In vivo SKELETAL MUSCLE ELECTROPORATION 
 
Experiments were performed on adult Atg7fl/fl or Atg7-/- mice tibialis anterior (TA) 
or flexor digitorium brevis (FDB). The animals were anesthetized by an 
intraperitoneal injection of xylazine (Xilor) (20 mg/Kg) and Zoletil (10 mg/Kg).  
Tibialis anterior (TA) muscle was isolated through a small hindlimb incision, and 
DNA was injected along the muscle length. Electric pulses were then applied by two 
Cre      M    -     +   +    +    -     +    +  H2O 
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stainless steel spatula electrodes placed on each side of the isolated muscle belly (50 
Volts/cm, 5 pulses, 200 ms intervals). Muscles were analyzed 14 days later. No 
evidence of necrosis or inflammation as a result of the transfection procedure were 
observed (Sandri et al., 2004 and Donà et al., 2003). 
Tibialis Anterior of Atg7-/- MLC mice were transfected with FGFBP1-V5 (20 μg) and 
GFP (5 μg) plasmids. Tibialis Anterior of control mice were transfected with oligos 
(25 μg) for knocking down experiments. 
 
FDB electroporation did not require muscle isolation. We injected 5 μl of 
Hyaluronidase (2mg/ml)(Sigma-Aldrich) in the feet of anesthetized mice, to soften 
muscle tissue underneath the epidermis. We waited 50 minutes to inject DNA and 
after 10 minutes electric pulses were applied by two stainless needles placed at one 
cm from each other (100V/cm) (100 Volts/cm, 20 pulses, 1 s intervals). Muscles 
were analyzed 7 days later. No evidence of necrosis or inflammation were observed 
after the transfection procedure. FDB of Atg7f/f HSA and Atg7-/- HSA mice were 
transfected with roGFP plasmid (15 μg).  
 
2.3 MEASUREMENTS OF MUSCLE FORCE IN VIVO 
 
Muscle force was measured in a living animal as previously described (Blaauw et al., 
2008). We performed this experiment in collaboration with Bert Blaauw (VIMM, 
Padua). Briefly gastrocnemius (GCN) muscle contractile performance was measured 
in vivo using a 305B muscle lever system (Aurora Scientific Inc.) in anaesthetized 
mice. Contraction was elicited by electrical stimulation of the sciatic nerve. The 
torque developed during isometric contractions was measured at stepwise 
increasing stimulation frequency, with pauses of at least 30 seconds between stimuli 
to avoid effects due to fatigue. Duration of the trains never exceeded 600 ms. Force 
developed by plantar flexor muscles was calculated by dividing torque by the lever 
arm length (taken as 2.1 mm). 
 
 
 
62 
 
2.4 HISTOLOGY ANALYSES AND FIBRE SIZE 
MEASUREMENTS 
 
Muscles were collected and directly frozen by immersion in liquid nitrogen. Then we 
cut muscle cryosections by using Cryostat (Leica CM 1950), 10μm thick for histology 
and 7μm thick for immunostaining analyses. TA Cryosections, 10μm thick, were 
used to analyze tissue morphology with different methods, listed below. Images 
were collected with an epifluorescence Leica DM5000B microscope, equipped with a 
Leica DFC300-FX digital charge-coupled device camera, by using Leica DC Viewer 
software. 
For electron microscopy, we used conventional fixation-embedding procedures 
based on glutaraldehyde-osmium fixation and Epon embedding. 
 
2.4.1 Haematoxylin and Eosin staining (H&E) 
Haematoxylin colors basophilic structures that are usually the ones containing 
nucleic acids, such as ribosomes, chromatin-rich cell nuclei, and the cytoplasmc 
regions rich in RNA. Eosin colors eosinophilic structures bright pink. The 
eosinophilic structures are generally intracellular or extracellular protein. 
The methods consist of: 
 
Materials Time 
3 washes in PBS 5 minutes each 
Harris Haematoxylin (Sigma-Aldrich) 1 minute 
Wash in running tap water 3 minutes 
Eosin Y Solution Alcoholic (Sigma-Aldrich) 1 minute 
Ethanol 50% 30 seconds 
Ethanol 70% 30 seconds  
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Ethanol 100% 5 minutes 
Ethanol 100% 10 minutes 
Xilen  3 minutes 
Mount with Eukitt (Sigma-Aldrich)  
 
2.4.2 Succinate dehydrogenase (SDH) 
The succinate dehydrogenase is an enzyme complex, bound to the inner 
mitochondrial membrane. With this staining it is possible to evaluate approximately 
the quantity of mitochondria present in the muscle fibres, through colorimetric 
evaluation. The reaction gives a purple coloration in the oxidative fibres. The 
sections were incubated for 30 minutes at 37°C with SDH solution (0.2M sodium 
succinate) (Sigma-Aldrich), 0.2M phosphate buffer (Sigma) ph 7.4 and 50mg of nitro 
blue tetrazolium (NBT)(Sigma-Aldrich). After the incubation, the sections were 
washed 3 minutes with PBS and then mounted with Mounting medium (Dako). 
 
2.4.3 Fibre Cross-Sectional Area (CSA) 
Fibre Cross-Sectional Area was measured, by using ImageJ software (National 
Institutes of Health). All data are expressed as the mean SEM (error bars). 
Comparisons were made by using t test, with *P<0.05 being considered statistically 
significant. 
 
2.5 IMMUNOHISTOCHEMISTRY ANALYSES 
 
TA muscle cryosections, 7 µm thick, were processed for immunostaining. All data 
are expressed as the mean SEM (error bars). Comparisons were made by using t 
test, with *P<0.05 being considered statistically significant. 
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2.5.1 NCAM staining 
Muscle cryosections were fixed with Methanol -20°C, treated with 0,1% Triton for 5 
minutes and incubated in blocking solution (0.5% BSA, 10% goat serum in PBS) at 
room temperature (RT) for 40 minutes. Samples were then incubated with the 
primary antibody against NCAM (Millipore) (dilution 1:200) at 4°C over-night. Then 
the sections were washed with PBS three times for 5 minutes and incubated with 
the anti-rabbit-Cy3-conjugated secondary antibodies (dilution 1:200) at 37°C for 1 
hour (Life Technologies). After the washes and incubation with DAPI, that labels 
nuclei, slides were mounted with mounting medium (Dako). 
 
2.5.2 MuSK staining 
Cryosections were fixed with PFA 4%, treated with 0,1% Triton for 5 minutes and 
incubated in blocking solution (0.5% BSA, 10% mouse serum in PBS) at RT for 40 
minutes. After that samples were incubated with the primary antibody against MuSK 
(kind gift from M. Ruegg), at 4°C over-night (dilution 1:200). Sections were then 
washed with PBS three times for 5 minutes and incubated with the anti-rabbit-Cy3-
conjugated secondary antibodies (dilution 1:200) at 37°C for 1hour (Life 
Technologies). After the washes, sections were incubated with anti-Bungarotoxin-
Alexa 488 (dilution 1:500) from Life Technologies at 37°C for 1 hour. After the 
washes and incubation with DAPI, slides were mounted with mounting medium 
(Dako).  
 
2.5.3 IgG staining 
Cryosections were incubated in blocking solution (0.5% BSA, 10% goat serum in 
PBS) at RT for 20 minutes. Samples were then incubated with anti-mouse-Cy3-
conjugated secondary antibodies (dilution 1:200) at 37°C for 1hour (Life 
Technologies). After the wash and incubation with DAPI, slides were mounted with 
mounting medium (Dako). 
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2.6 IMMUNOBLOTTING 
 
Cryosections of 20 μm of TA muscles were lysed with 100 μl of a buffer containing 
50 mM Tris pH 7.5, 150 mM NaCl, 10 mM MgCl2, 0.5 mM DTT, 1 mM EDTA, 10% 
glycerol, 2% SDS, 1% Triton X-100, Roche Complete Protease Inhibitor Cocktail and 
Sigma Protease Inhibitor Cocktail. After incubation at 70°C for 10 minutes and 
centrifugation at 11000 g for 10 minutes at 4°C, the surnatant protein concentration 
was measured using BCA protein assay kit (Pierce) following the manufacturer’s 
instructions. 
 
2.6.1 Protein gel Electrophoresis 
The extracted proteins from TA muscle were solubilized in Loading buffer composed 
by 5μl of 4X NuPAGE® LDS Sample Buffer (Life Technologies) and 1μl of 20X DTT 
(Life Technologies). The volume of each sample was brought to 20μl with TBS 1X. 
The samples were denaturated at 70°C for 10 minutes.  
Samples were loaded on SDS 4-12% precast polyacrylamide gels (NuPAGE Novex-
Bis-tris-gels) or in SDS 3-8% depending on the protein to be analyzed (Life 
Technologies). The electrophoresis was run in 1X MES Running buffer or 1X Tris-
Acetate Running buffer respectively (Life Technologies) for 1 hour and 30 minutes 
at 150V constant. 
 
2.6.2 Transfer of the protein to the PVDF membrane 
After the electrophoretic run, proteins were transferred from gels to PVDF 
membranes, previously activated with methanol. The gel and the membrane were 
equilibrated in Transfer Buffer. The Transfer Buffer was prepared as follows: 50 ml 
of 20X NuPAGE® Transfer buffer (Life Technologies), 1 ml of 10X NuPAGE® 
Antioxidant (Life Technologies), 200 ml of 20% Methanol (Sigma-Aldrich). The 
volume was brought to 1l with distilled water. The blotting was obtained by 
applying a current of 400mA for two hours at 4°C. To evaluate the efficiency of the 
transfer, proteins were stained with Red Ponceau 1x (Sigma-Aldrich). The staining 
was easily reversed by washing with distilled water. 
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2.6.3 Incubation of the membrane with antibodies 
 
Once the proteins were transferred on PVDF membranes, the membranes were 
saturated with Blocking Buffer (5% no fat milk powder solubilized in TBS 1X with 
0.1% TWEEN) for 1 hour at room temperature and were incubated overnight with 
various primary antibodies at 4°C . Membranes were then washed 3 times with TBS 
1X with 0.1% TWEEN at RT and incubated with secondary antibody-HRP Conjugate 
(Bio-Rad), for 1 hour at room temperature. 
Immunoreaction was revealed by SuperSignal West Pico Chemiluminescent 
substrate (Pierce) and followed by exposure to Xray film (KODAK Sigma-Aldrich). 
 
Antibodies Companies 
Catalogue 
number 
Anti-ATG7 Sigma-Aldrich A2856 
Anti-p62 Sigma-Aldrich P0067 
Anti-LC3 Sigma-Aldrich L7543 
anti-V5 Life technologies 46-0705 
anti-βtubulin Sigma-Aldrich T8328 
anti-GAPDH Abcam-Aldrich AB8245 
anti-pan actin Sigma-Aldrich AC40 
anti-GFP Life technologies A11122 
anti-NCAM Millipore AB5032 
Secondary Antibodies   
anti- mouse Biorad 170-6516 
anti-rabbit Biorad 170-6515 
 
Tab. 1: Antibodies used for western blot analyses. 
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All the peroxidase-conjugated secondary antibodies were from Bio-Rad. Blots were 
stripped using Stripping Solution, containing 25mM glycine and 1% SDS, pH 2. 
 
2.7 FUNCTIONAL ASSAYS ON SINGLE MUSCLE FIBRES 
 
All these experiments were done in collaboration with the group of Prof. Bottinelli 
(Physiology department, University of Pavia). 
 
2.7.1 Single fibre dissection and experimental set-up 
The method used for single muscle fibres dissection, the solutions and the 
experimental set-up have been previously described (Bottinelli et al., 1996). Briefly, 
after animal sacrifice, muscle bundles were prepared and stored at -20°C. On the day 
of the experiment, single muscle fibres were dissected from a bundle with the help 
of a stereomicroscope. Segments of muscle fibres were chemically skinned and 
attached in the experimental setup. Relaxing (5mM EGTA pCa 9.0), pre-activating 
(0.5mM EGTA pCa 9.0) and activating (pCa 4.5) solutions were prepared as 
previously described (Bottinelli et al., 1996). The set up was placed on the stage of 
an inverted microscope (Axiovert 10, Zeiss, Germany) which allowed us to view the 
fibre at x 320 magnification. In this way, we measured the force generated by each 
fiber and their speed of contraction. The signals from the force and displacement 
transducer were fed into a personal computer and analyzed by a data analysis 
software (Spike 2, CED,Cambridge, UK). 
 
2.7.2 Single fibre analysis 
Single fibre analysis was performed as previously described (Bottinelli et al., 1996). 
The experiments were performed at the temperature of 12°C. Sarcomere length was 
determined and set at 2.5µm. The cross sectional area (CSA) of the fibres was 
determined without correction for swelling. Absolute (Po) and specific force 
(Po/CSA) of the fibres were determined. At the end of the mechanical experiment 
fibres were put in 20 μl of Laemmli buffer and stored at –20 °C for subsequent 
electrophoretic analysis of myosin heavy chains (MHC) isoform content.  
68 
 
 
2.7.3 Contractile proteins for IVMA  
Myosin extraction from bulk muscles 
Myosin isoform 2B was extracted from bulk gastrocnemius muscles of mice 
according a procedure previously described in detail (Canepari et al., 2000) and 
used to prepare heavy meromyosin fraction (HMM). 
Heavy meromyosin (HMM) preparation 
HMM was obtained by a proteolytic digestion with -chimotrypsin of myosin 
according to a modification of the method of Margossian and Lowey (Margossian 
and Lowey, 1982) previously described in detail (Canepari et al., 2000). 
Actin preparation 
G Actin was extracted as described by Pardee and Spudich (Pardee and Spudich, 
1982) from acetone powder prepared from the residues of mice muscles after 
myosin extraction. After polymerization, F actin was labeled by incubation for 
several hours with rhodamine-phalloidine (Molecular Probes R415) as described by 
Kron et al (Kron et al., 1991).   
 
2.7.4 In Vitro Motility Assay (IVMA) 
In this assay actin and myosin are purified, then actin is labeled with rhodamine 
falloidine and allowed to move over myosin molecules that were previously linked 
onto a glass slide. When ATP is added, the actin-myosin complexes move out from 
the in rigor state and the actin movement and velocity of sliding on myosin is 
measured. 
Myosin (or HMM ) was diluted to 0.1 mg/ml in a high (or low) ionic strength buffer 
and infused in a flow cell treated with nitrocellulose and prepared according to 
Anson et al (Anson et al., 1995). The IVMA analysis was performed according to 
Canepari et al. (Canepari et al., 2000; Canepari et al., 1999) at the temperature of 
25°C. The composition of the experimental buffer was MOPS 25mM (pH=7.4 at 
25°C), KCl 25mM, MgCl2 4mM, EGTA 1mM, DTT 1mM, glucose oxidase 200 μ/ml, 
catalase 36μg/ml, glucose 5 mg/ml, ATP 2mM. Average velocities of actin filaments 
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were determined for each myosin and HMM sample, the velocities of at least 50 
filaments were measured and their distribution characterized according to 
parametric statistics. 
 
2.8 IN VIVO MICROSCOPY AND ANALYSIS OF ACHR 
TURNOVER AND NMJ FRAGMENTATION 
 
We performed these experiments in collaboration with the group of Dr. Rudolf (KIT- 
Karlsruhe Institute of Technology, Karlsruhe). Bungarotoxin-Alexa 488 (1:100 
dilution from 1mg/ml stock solution) (Life Technologies) was injected in the TA of 
an anesthetized mice, then after 10 days, a second injection of Bungarotoxin-Alexa 
594 was performed in the same TA muscle of each mice. Mice that were previously 
transfected with specific plasmids had the first injection after 5 days of transfection. 
In vivo microscopy of mice was performed under anesthesia using Xylazine (Xilor) 
(20 mg/Kg) and Zoletil (10 mg/Kg) on a Leica SP2 confocal microscope equipped 
with a 63x 1.2 N.A. water immersion objective, essentially as described previously 
(Roder et al., 2010; Roder et al., 2008). Automated analysis of AChR turnover and 
NMJ fragmentation used algorithms described earlier (Roder et al., 2010). 
 
2.9 GENE EXPRESSION ANALYSIS 
 
Quantitative Real-time PCR was performed with SYBR Green chemistry (Applied 
Biosystems). SYBR green is a fluorescent dye that intercalates into double-stranded 
DNA and produces a fluorescent signal. The Real-Time PCR Instrument allows real 
time detection of PCR products as they accumulate during PCR cycles and create an 
amplification plot, which is the plot of fluorescence signal versus cycle number. In 
the initial cycles of PCR, there is little change in fluorescence signal. This defines the 
baseline for the amplification plot. An increase in fluorescence above the baseline 
indicates the detection of accumulated PCR products. A fixed fluorescence threshold 
can be set above the baseline. The parameter Ct (threshold cycle) is defined as the 
fractional cycle number at which the fluorescence passes the fixed threshold. So the 
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higher the initial amount of the sample, the sooner the accumulated product is 
detected in the PCR process as a significant increase in fluorescence, and the lower is 
the Ct value. 
 
2.9.1 Quantification of the PCR products and determination of 
the level of expression 
 
A relative quantification method were used to evaluate the differences in gene 
expression, as described by Pfaffl (Pfaffl, 2001). In this method, the expression of a 
gene is determined by the ratio between a test sample and a housekeeping gene. The 
relative expression ratio of a target gene is calculated based on the PCR efficiency 
(E) and the threshold cycle deviation (∆Ct) of unknown samples versus a control, 
and expressed in comparison to a reference gene. 
The mathematical model used for relative expression is represented in this 
equation: 
 
 
The internal gene reference used in our real time PCR was pan-actin, whose 
abundance did not change under the experimental conditions. 
 
2.9.2 Primer pairs design 
 
Gene-specific primer pairs were selected with Primer Blast software 
(http://www.ncbi.nlm.nih.gov/tools/primer-blast/). Primer pairs were selected in a 
region close to the 3'-end of the transcript, and amplified fragments of 150-250bp in 
length. To avoid the amplification of contaminant genomic DNA, the target 
sequences were chosen on distinct exons, separated by a long (more than 1000bp) 
intron. The melting temperature was chosen to be of about 58-60° C. The sequences 
of the primer pairs are listed in Table 2. 
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qRT-PCR primer Oligo Sequence (5’-3’) 
m-AchRγ 
Fw: CAGTGGGGGACCTAGAAACA 
Rev: ACCTTTCCAATCCACAGCAC 
m-MuSK 
Fw: ATCACCACGCCTCTTGAAAC 
Rev: TGTCTTCCACGCTCAGAATG 
m-FGFBP1 
Fw: CGCACGCTGCGCAAACAGAA 
Rev: TCCACGTGCGTTGGGGTTCA 
m-Neurotrophin 3 
Fw: GCCAGGCCGGTCAAAAACGG 
Rev: TCCAGCGCCAGCCTACGAGT 
m-GDNF 
Fw: TCGCGCTGACCAGTGACTCCAA 
Rev: GGAAGCGCTGCCGCTTGTTT 
m-BDNF 
Fw: AATGGCCCTGCGGAGGCTAA 
Rev: AGGGTGCTTCCGAGCCTTCCTT 
m-PAN-ACTIN 
Fw: CTGGCTCCTAGCACCATGAAGAT 
Rev: GGTGGACAGTGAGGCCAGGAT 
m-h-GAPDH 
Fw: TGCACCACCAACTGCTTAGC 
Rev: GGCATGGACTGTGGTCATG 
h-FGFBP1 
Fw: TCAGAACAAGGTGAACGCCCAGC 
Rev: GTGAGCGCAGATTCCGGGCA 
 
Tab. 2: Sequence of primers used in q-RT-PCR analyses. 
 
 
2.9.3 Extraction of total RNA 
Total RNA was isolated from TA using Trizol (Life Technologies) following the 
manufacturer’s instructions. 
 
2.9.4 Synthesis of the first strand of cDNA 
400ng of total RNA was reversly transcribed with SuperScriptTM III (Life 
Technologies) in the following reaction mix: 
Random primer hexamers (50ng/μl random): 1μl 
dNTPs 10 mM: 1μl 
H2O Rnase-free: 8.5μl 
 
The samples were mixed and briefly centrifuged and denaturised by incubation for 5 
minutes at 65°C to prevent secondary structures of RNA. 
 
Samples were incubated on ice for 2 minutes to allow the primers to align to the 
RNA, and the following components were added sequentially: 
First strand buffer 5X (Life Technologies): 5μl 
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DTT 100mM: 2μl 
RNase Out (Life Technologies): 1μl 
SuperScriptTM III (Life Technologies): 0.5μl 
The volume was adjusted to 20ul with RNase free water. 
The used reaction program was: 
step1: 25°C for 10 minutes 
step2: 42°C for 50 minutes 
step3: 70°C for 15 minutes 
At the end of the reaction, the volume of each sample was adjusted to 50ul with 
RNase free water. 
 
2.9.5 Real-Time PCR reaction 
 
1μl of diluted cDNAs was amplified in 10μl PCR reactions in a ABI Prism 7000 
(Applied Biosystem) thermocycler, coupled with a ABI Prism 7000 Sequence 
Detection System (Applied Biosystems) in 96-wells plates (Micro Amp Optical, 
Applied Biosystems). In each well 5ul Sample mix and 5ul reaction mix were mixed. 
Sample mix was prepared as follows for 5 μl total volume: 
Template cDNA: 1 μl 
H2O Rnase-free: 4 μl 
 
The SYBR Green qPCR (Applied Biosystem) was used for the Real-Time PCR reaction 
as follows: 
SYBR Green qPCR (Applied Biosystem): 4.8μl 
Mix Primer forward /reverse 50mM: 0.2μl 
 
The PCR cycle used for the Real-Time PCR was: 
step 1: 95° C for 15 minutes 
step2: 95° C for 25 seconds 
step3: 58° C for 1 minute 
step4: go to step 2 for 40 times 
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2.10 PLASMID CLONING  
 
The cloning strategy required insertion of the DNA of  intrest in a specific plasmid. 
Then competent bacteria (Top 10) (Life Technologies) were transformed and the 
plasmid was purified first with Mini-prep kit (Machery-Nagel) and then, to increase 
the quantity of DNA, in particular for in vivo transfection, we prepared Maxi-prep 
(Qiagen) following the manufacturer’s instructions. Final DNA concentration was 
quantified by Nanovue Plus (GE Haelthcare). 
 
2.10.1 FGFBP1 cloning 
FGFBP1 was amplified from mouse cDNA by PCR using the following primers Fw: 
ACCATGAGACTCCACAGCCTC and Rev: GCATGATGTCGCCTGTAACAT. The PCR 
fragments then were cloned into pcDNA3.1-V5-HISTOPO vector (Life Technologies). 
 
2.10.2 In Vivo RNAi 
Oligos were cloned into Life Technologies BLOCK-IT Pol II miR RNAi Expression 
Vectors. For validation of shRNA constructs, C2C12 cells were maintained in 
DMEM/10%FBS and transfected with shRNA constructs using Lipofectamine 2000 
(Life Technologies) according to manufacturer’s instructions. Cells were lysed 24 
hours later, and immunoblotting was performed as described below. The sequences 
of the Oligos Used for shRNA Production are listed in the Table 1: 
 
shRNA 
oligos 
Oligo sequence (5’-3’) 
FGFBP1- 
oligo 1 
Fw: TGCTGTATTCTGGGCCTTCCCTAACGGTTTTGGCCACTGACTGACCGTTAGGGGGCCCAGAATA 
Rev: CCTGTATTCTGGGCCCCCTAACGGTCAGTCAGTGGCCAAAACCGTTAGGGAAGGCCCAGAATAC 
FGFBP1- 
oligo 2 
Fw: TGCTGTGCACTGGACCTTCAGGCTGAGTTTTGGCCACTGACTGACTCAGCCTGGGTCCAGTGCA 
Rev: CCTGTGCACTGGACCCAGGCTGAGTCAGTCAGTGGCCAAAACTCAGCCTGAAGGTCCAGTGCAC 
FGFBP1- 
oligo 3 
Fw: TGCTGTTCTGAGAACGCCTGAGTAGCGTTTTGGCCACTGACTGACGCTACTCACGTTCTCAGAA 
Rev: CCTGTTCTGAGAACGTGAGTAGCGTCAGTCAGTGGCCAAAACGCTACTCAGGCGTTCTCAGAAC 
FGFBP1- 
oligo 4 
Fw:TGCTGTTAGCATGATGTCGCCTGTAAGTTTTGGCCACTGACTGACTTACAGGCCATCATGCTAA 
Rev: CCTGTTAGCATGATGGCCTGTAAGTCAGTCAGTGGCCAAAACTTACAGGCGACATCATGCTAAC 
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MuSK- 
oligo 1 
Fw: TGCTGAAATATGGCAGTCTTGTGCAGGTTTTGGCCACTGACTGACCTGCACAACTGCCATATTT 
Rev: CCTGAAATATGGCAGTTGTGCAGGTCAGTCAGTGGCCAAAACCTGCACAAGACTGCCATATTTC 
MuSK- 
oligo 2 
Fw: TGCTGTTAGGTTTCATCTTCACTTGCGTTTTGGCCACTGACTGACGCAAGTGAATGAAACCTAA 
Rev: CCTGTTAGGTTTCATTCACTTGCGTCAGTCAGTGGCCAAAACGCAAGTGAAGATGAAACCTAAC 
 
Tab. 3: Sequence shRNA used for in vivo transfection 
 
 
2.10.3 Cell culture and transient transfection 
 
C2C12 myogenic cell line were cultured in DMEM (GIBCO-Life Technologies) 
supplemented with 10% foetal bovine serum. Myoblasts were transfected using 
Lipofectamine 2000 (Life Technologies) according to the manufacturer’s 
instructions.  
 
2.11 PROTEIN CARBONYLS DETECTION 
  
We used the Oxyblot assay to evaluate ongoing protein carbonylation in skeletal 
muscle. Extensor Digitorum Longus (EDL) muscles were lysed in lysis buffer with 
50mM of DTT. The composition of the lysis buffer is similar to that used for protein 
extraction. The samples were then incubated at 70°C for 10 minutes in a 
termomixer, and centrifuged at 11000 g for 10 minutes at 4°C. Then 15 µg of protein 
lysates were derivatized with 2,4dinitrophenylhydrazine (DNPH) solution and then 
neutralized. This way the samples can be separated on SDS-PAGE (12% (v/v) 
polyacrylamide) and electro blotted onto nitrocellulose membranes. After blocking, 
membranes were incubated with anti-DNP antibody (Sigma-Aldrich), washed, and 
incubated with peroxidase conjugated anti-rabbit IgG antibodies. Immunoreaction 
was revealed by SuperSignal West Pico Chemiluminescent substrate (Pierce) and 
followed by exposure to Xray film (KODAK Sigma-Aldrich). Quantification analysis 
was performed with ImageJ Software and all values were normalized for the 
housekeeping gapdh. 
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2.12 EXERCISE PROTOCOL 
 
Atg7f/f and Atg7-/- HSA mice performed one day of concentric exercise on a treadmill 
(LE 8710 Panlab Technology 2B, Biological Instruments), with 10 degrees incline, at 
increasing velocity, according to the protocol of acute exercise previously described 
(He et al., 2012).  
The eccentric training protocol consisted of 3 days running to exhaustion, with a 10 
degree decline, at increasing velocity, according to the protocol of exercise 
previously described (He et al., 2012). 
Briefly, exercise consists in 17 cm/sec for 40 minutes, 18 cm/sec for 10 min, 20 
cm/sec for 10 min, 22 cm/sec for 10 min, and then increasing velocity of 1cm/sec 
and or 2 cm/sec alternatively every 5 minutes, until they were exhausted. 
Exhaustion was defined as the point at which mice spent more than 5 s on the 
electric shocker without attempting to resume running.  
Total running distance and time were recorded for each mouse. All procedures are 
specified in the projects approved by the Italian Ministero Salute, Ufficio VI 
(authorization numbers C65). 
 
2.13 ANTI-OXIDANT TREATMENT  
 
Atg7f/f and Atg7-/- MLC mice were intraperitoneally injected with Trolox (Sigma-
Aldrich) 30mg/kg daily for four weeks. Trolox is a general anti-oxidant because it is 
an analogue of vitamin E. 
Females Atg7f/f and Atg7-/- HSA mice were treated with N-Acetyl-Cysteine (NAC) 
(Sigma-Aldrich A9165), for 6 weeks. We used 1% NAC drinking water for 5 weeks 
and 2% NAC drinking water for the last week. The treatment was also maintained 
during exercise training. NAC is a general anti-oxidant because it is a thiol 
antioxidant. 
Another group of females Atg7f/f and Atg7-/- HSA mice were then treated with 
intraperitoneal injections of Mito-TEMPO (Enzo Life Science) 1.4 mg/kg daily for 7 
days. Mito-TEMPO is a specific anti-oxidant, because it is a mitochondria-targeted 
superoxidant dismutase mimetic (Dikalova et al., 2010). 
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2.14 ANALYSES OF MITOCHONDRIAL MEMBRANE 
POTENTIAL IN ISOLATED SINGLE FIBRES  
 
Mitochondrial membrane potential was measured in isolated fibres from flexor 
digitorum brevis (FDB) muscles. FDB muscle was incubated in a DMEM (GIBCO-Life 
Technologies) and Collagenase (4mg/ml)(GIBCO-Life Technologies) solution for 
about one hour and 45 minutes at 37°C. Then single fibres were dissected with the 
pipet with the help of a stereomicroscope. Mitochondrial membrane potential was 
measured by epifluorescence microscopy based on the accumulation of TMRM 
fluorescence as previously described (Romanello et al., 2010). Single fibres were 
incubated with TMRM (Tetramethylrhodamine, methyl ester)(Life Technologies) a 
fluorescent lipophilic cationic molecule that accumulates in mitochondria in a 
potential-dependent manner. The solution contains also glucose (3,5 g/l), to sustain 
the fibres during the experiment and Cyclosporin H (8mM) (Enzo Life Science), to 
block mitochondrial pumps, that would transport TMRM outside the mitochondria. 
In this experiment we need to perturbed the system with Oligomycin (4 µM)(Sigma-
Aldrich), that is an ATP-syntase inhibitor, because ATP-synthase can reversely 
transport protons across the inner mitochondrial membrane, so maintaining the 
potential also in dysfunctional mitochondria. For this reason, only this treatment 
allow us to detect real dysfunctional mitochondria, that would inevitably dissipate 
the potential, loosing TMRM signal. At the end, we add an uncoupling agent FCCP 
(Trifluorocarbonylcyanide Phenylhydrazone) (4 µM)(Sigma-Aldrich), as 
experimental control. All the images were analyzed with ImageJ Software, and we 
considered fibres as depolarized when they have lost more than 10% of the initial 
value of TMRM fluorescence. 
 
2.15 MITOCHONDRIAL OXIDATIVE STRESS MEASUREMENT 
 
Mt-roGFP1 is an indicator of mitochondrial redox status (Dooley et al., 2004; Hanson 
et al., 2004). It measures the thiol/disulfide equilibrium in the mitochondrial matrix. 
We transfected FDB muscles of females Atg7f/f and Atg7-/- HSA mice with mt-roGFP 
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plasmid, that is targeted to the mitochondria, one week before exercise. Then we 
measured the fluorescence in single muscle fibres, that were isolated prior to and 
after exercise. Mt-roGFP1 fluorescence (excitation: 405 and 480 nm, emission: 535 
nm, 20X objective) was measured for 5 minutes every 10 seconds. The ratio of 
fluorescence intensities (exc. 405/480) were computed. Records were analyzed 
with ImageJ Software. 
 
2.16 BLOOD METABOLITES QUANTIFICATION 
 
This analysis was performed in collaboration with the group of Prof. Avogaro 
(Venetian Institute of molecular medicine, VIMM, Padova). Blood samples were 
collected before exercise and immediately after the 3 days of exercise. Blood was 
collected from the orbital sinus in heparin-coated pasteur pipettes and centrifuged 
immediately after collection. Plasma samples were kept at -20°C until dosing. 
Blood glucose and lactate levels were measured with an YSI 2300 STAT Plus™ 
Glucose & Lactate Analyzer (YSI Life Sciences, Yellow Springs, OH) according to the 
manufacture's instruction. Free fatty acids (FFAs) and beta-hydroxybutyrate were 
dosed using an automated spectrophotometer Cobas Fara II (Roche) according to 
the manufacture’s instruction.  
 
2.17 STATISTICAL ANALYSES 
 
Survival probability evaluated by using Kaplan-Meier method. Comparison of Atg7f/f 
and Atg7-/- survival curves was performed by both Mantel-Cox and Gehan-Breslow-
Wilcoxon tests.  
Comparisons were made by using t test, with p<0.05 being considered statistically 
significant (*p<0.05, **p<0.01, ***p<0.001). Values are indicated in the graphs by 
mean +/- standard error. 
78 
 
 
79 
 
3. RESULTS 
PART I 
3.1 ANALYSIS OF AUTOPHAGY PROCESS DURING AGEING  
 
Initially we identified the level of the autophagy-lysosome pathway during ageing; 
for this reason we monitored autophagy in control animals, analyzing both adult (10 
months old) and aged mice (26 months old). As indicator of autophagy, we analyzed 
ATG7 and LC3 protein levels. Aged mice showed a decrease of ATG7 and LC3 
lipidation suggesting that autophagy is not only reduced, but impaired during ageing 
(Figure 1A). We also evaluated autophagy level in human biopsies from young (25 
years old), old sedentary (70 years old), and old sportsmen (70 years old), that 
confirmed the finding observed in mice. LC3 lipidation and Atg7 level were 
dramatically reduced in old sedentary subjects (Figure 1B). Moreover, it is 
important to underline that autophagy is reactivated through physical exercise in 
elder people. 
 
 
Fig. 1: Levels of autophagy proteins in aged mice (A) human biopsies (B). (A) Representative 
immunoblotting for the critical E1-like enzyme, ATG7, LC3-II and LC3-I on muscle extracts from 
gastrocnemius of 10 and 26 months old mice. The graphs show the quantification of Atg7 
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protein and the LC3-II/LC3-I ratio. Values are mean +/- s.e.m., n=4 per condition, *p<0.05. (B) 
Ageing reduces, while exercise maintains expression of ATG7 and LC3 lipidation in humans. The 
graphs show the quantification of ATG7 protein and LC3-II/LC3-I ratio revealed by 
immunoblotting on muscle biopsies. Values are mean +/- s.e.m., n=6 young, n=10 old sedentary 
and n=4 senior sportsmen, ***p<0.0001. 
 
3.2 AUTOPHAGY INHIBITION EXACERBATES THE FEATURES 
OF AGEING SARCOPENIA 
 
In order to understand the role of autophagy during ageing we characterized 
muscle-specific autophagy deficient mice, hereafter reported as Atg7-/- and control 
animals (Atg7f/f). We analized adult mice (2, 5 and 10 months old) and aged ones (26 
months old). Initially we monitored lifespan expecting that the inhibition of the 
second major protein degradation pathway would ameliorate the atrophic condition 
associated with ageing. Surprisingly Atg7-/- mice showed a significant reduction of 
survival (Figure 2A). Then we characterized the typical features of sarcopenia in 
these mice. We first monitored muscle morphology and measured muscle mass. 
H&E staining of aged animals revealed the presence of atrophy, center-nucleated 
fibres and inflammation in Atg7 deficient muscles compared to age-matched 
controls (Figure 2B). Fibre size was dramatically reduced in Atg7-/- and fibres 
displayed a great variability in dimension. In particular, we found extremely small 
fibers that made them hardly detectable (Figure 2C). We confirmed that those fibres 
were adult atrophic myofibres, and not regenerating fibers, as revealed by the 
absence of embryonic or neonatal isoforms of Myosin Heavy Chain, two markers or 
regeneration (data not shown). In order to quantify the atrophic condition we 
measured the fibre cross sectional area (CSA). CSA measurements confirmed that 
aged Atg7-/- presented an exacerbated atrophic phenotype compared to age matched 
controls (Figure 2D). Further analyses revealed that atrophy was exacerbated in 
glycolytic fibres (Figure 2E). The deterioration of Atg7-/- muscle was also confirmed 
by the significant increase of centre-nucleated fibres (Figure 2F), that are considered 
a typical sign of myopathy. 
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Fig. 2: (A) Surival curve of autophagy deficient mice, they die earlier compared to control ones. 
Survival probability evaluated by using Kaplan-Meier method. Comparison of Atg7f/f and Atg7-/- 
survival curves was performed by both Mantel-Cox and Gehan-Breslow-Wilcoxon tests. (n>10 
for each group) (p0.05). (B-F) Atg7-/- are myopathic and atrophic as revealed by H&E staining 
and measure of CSA and centre-nucleated fibres. Values are mean +/- s.e.m., n>4 for each group, 
*p<0.05 **p<0.01.   
 
Considering that atrophy is often associated with a decrease in functionality we 
measured muscle force in vivo. In this assay, increasing electrical stimuli are applied 
to sciatic nerve of an anesthetized mouse in order to induce muscle contraction, and 
so force generation untill the maximum tetanic force is reached. In this way it is 
possible to measure the maximum force generated by a single muscle in living 
animals. We found that Atg7-/- muscles were weaker than controls in adulthood and 
in aged mice (Figure 3 A-B). This result indicated that Atg7 deficient muscles had an 
impaired functionality. Interestingly, the strength of adult Atg7-/- mice was 
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comparable to the force generated by 26 months old controls suggesting an ongoing 
precocious ageing. Given that muscle atrophy and weakness are exacerbated in 
autophagy-deficient muscles, and that a decline in innervation and loss of motor 
units are known to be important endogenous causes of sarcopenia, we tested 
whether the ageing-associated muscle loss was due to a possible ongoing 
denervation process. We first evaluated the expression pattern of Neural Cell 
Adhesion Molecule (N-CAM), that is a well defined re-innervation marker. NCAM 
localizes specifically at the neuromuscular junction (NMJ) level in innervated 
myofiber, but after denervation it is expressed along the entire fibres. Therefore, 
NCAM localization is used as a marker of denervation. As expected, aged control 
animals showed some NCAM positive however autophagy-deficient muscles 
displayed 5-7 fold more NCAM-positive fibres when compared to age-matched 
controls in both adulthood and elderly (Figure 3 C-E).  
 
 
Fig. 3: (A) Atg7-/- mice show a profound decrease in maximal force generation in adult animals. 
Values are mean +/- s.e.m., (n=5), **p<0.01. (B) Ageing reduces force production in both Atg7f/f 
and Atg7-/- mice, therefore aggravating the already profound weakness of Atg7-/- mice. Values 
are mean +/- s.e.m., n=4, *p<0.05. (C) Representative images of immunostaining for NCAM in 
aged mice. (D) Immunoblotting for NCAM protein on muscle extracts from adult and aged GCN 
muscles. Atg7-/- muscles express higher levels of NCAM than age-matched Atg7f/f. (E) 
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Quantification of NCAM-positive fibers. Values were normalized for the total number of 
myofibers in muscle section (at least 4 muscles per group were analysed, **p<0.01). Atg7-/- mice 
are characterized by much higher age-dependent increase in NCAM positive fibers than age-
matched Atg7f/f. (F) Expression levels of acetylcholine receptor (AChR) ɣ-subunit (left), and 
MuSK (right). MuSK and AChR are up-regulated in adult and aged Atg7-/- muscles (*p<0.05, 
n>5). (G) Quantification of Myosin type I fibres, that is a typical hallmark of ageing. Adult   
Atg7-/- showed a number of Myosin type I fibres comparable to aged control mice. Values were 
normalized for the total number of myofibers in muscle section (at least 4 muscles per group 
were analysed, *p<0.05) 
 
We then monitored the expression of two other markers of denervation, MuSK and 
acetylcholine receptor (AChR) ɣ-subunit that are strongly induced upon 
denervation. Notably, both these genes were significantly more induced in Atg7-
deficient muscles (Figure 3F). We also evaluated the number of myosin type I fibres, 
that is another marker of ageing. Indeed we found an increased number of these 
fibres in adult autophagy deficient mice when compared to aged-matched controls, 
(Figure 3G), suggesting an precocious ageing process in adult Atg7-/- mice.  
To further investigate this aspect, we analyzed NMJ morphology and stability in 
living animals. This was possible trough an in vivo imaging approach that used the 
two photon confocal microscopy. In this assay Acetylcholine Receptors (AChR) of 
tibialis anterior (TA) muscle were pulse-labeled with a-bungarotoxin conjugated 
with different fluorophores, in these way, colour shows both shape and stability of 
NMJ. In fact the colour prevalence of first or second injected fluorophore indicates 
old or new receptors, respectively. A shift in the fluorescence reveals an instability 
of NMJ. Automated image analysis showed an significant increase of fragmented NMJ 
in adult Atg7-/- mice and a higher new receptor/old receptor ratio (Figure 4A-B). 
Moreover it is interesting notice that while in controls the changes in NMJ 
morphology and stability progressively worsen with age, this was not the case in 
Atg7-/-. Notably, NMJs of both adult and aged Atg7-/- animals showed significantly 
more fragmentation and AChR turnover than 26 months aged control animals 
(Figure 4C). Indeed, while in control animals the amount of fragmented NMJs 
increased from 24.0 ± 1.8% (mean ± SEM, n = 4) in adult to 40.1 ± 11.6% (mean ± 
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SEM, n = 2) in aged mice, Atg7-/- muscles exhibited 70.7 ± 4.5% (mean ± SEM, n = 6) 
and 77.4 ± 2.7% (mean ± SEM, n = 6) fragmented synapses. 
An important kinase specifically localized in postsynaptic region of NMJ is Muscle 
Specific Kinase (MuSK). MuSK controls a plethora of signalling pathways that are 
important for NMJ development and stability. The specific localization of MuSK in 
correspondence of NMJ is essential for its correct function. For this reason, we 
checked whether alteration in autophagy might also affect MuSK localization. 
Immunohistochemistry on control muscle sections revealed that most of MuSK 
signal correctly co-localized with AChR at the plasma membrane. Importantly, 
absence of autophagy caused a significant loss of MuSK at the myofiber plasma 
membrane and a concomitant enrichment of internalised MuSK protein (Figure 4D, 
E). Therefore, this set of experiments suggests that block of autophagy leads to 
precocious appearance of morphological and physiological features of denervation. 
 
 
 
Fig. 4: (A) (B) Representative images of Atg7f/f and Atg7-/- neuromuscular junctions (NMJ) 
obtained using confocal in vivo microscopy. Muscles were in vivo pulse-labelled with 
bungarotoxins (BGT) conjugated with different fluorophores. BGT-AlexaFluor647 (shown in 
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green) was injected 10 days before microscopy thus identifying stable AChR, while BGT-
AlexaFluor555 (shown in red), injected 1 hour prior to microscopy, identifies newly 
incorporated AChR. Micrographs show representative maximum z-projections of confocal in 
vivo images of NMJs from Atg7f/f (A) and Atg7-/- (B). (C) Quantification of the AChR turnover as 
a function of NMJ fragmentation of adult and aged Atg7f/f versus Atg7-/-. Analysis was done 
using custom-made algorithms as described previously (Roder et al., 2010). Data from at least 4 
muscles per group, **p<0.01, *p<0.05. (D) Immunohistochemistry of MuSK expression on aged 
Atg7f/f and Atg7-/- myofibers. Upper panel shows normal pattern of NMJs in Atg7f/f mice, where 
MuSK (red) localizes to NMJ, revealed by BGT-AlexaFluor647 (green). Lower panel shows MuSK 
(red) that accumulates inside myofibers at the level of NMJ (green). (E) Quantification of the 
amount of diffused MuSK staining normalized over the total number of MuSK positive NMJs is 
higher in Atg7-/- than Atg7f/f; **p<0.01. 
 
 
3.3 AUTOPHAGY INHIBITION ENHANCES OXIDATIVE 
STRESS AND MITOCHONDRIAL DYSFUNCTION 
 
During ageing accumulation of dysfunctional mitochondria occurs thus contributing 
to an increased production of reactive oxygen species (ROS) and oxidative stress. It 
has been shown that adult autophagy-deficient mice present abnormal 
mitochondria, so we monitored mitochondria morphology in aged muscles. 
Succinate dehydrogenase (SDH) staining revealed an accumulation of mitochondria 
in aged autophagy deficient mice (Figure 5A). Electron microscopy showed an 
abnormal mitochondria morphology with cristae (Figure 5B). Since altered 
morphology is often associated with impairment in function we analyzed 
mitochondria functionality by evaluating their capability to maintain membrane 
potential. We performed TMRM assay on flexor digitorium brevis (FDB) single 
muscle fibres of adult mice (10 moths old). We did not perform the same assay in 
aged mice because of technical difficulties due to the condition of muscle tissue. 
While control mitochondria maintain membrane potential, after oligomycin 
addition, mitochondria of Atg7-/- did lose the potential (Figure 5C), thus revealing 
mitochondria dysfunction of Atg7-/- mice. Impairment in function leads to 
exacerbated ROS production, that we monitored by evaluating overall protein 
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carbonylation, that indeed was increased in Atg7-/- mice (Figure 5D). Atg7-/- muscles 
showed two-fold increase of carbonylated proteins when compared to age-matched 
controls.  
 
 
 
Fig. 5: (A) SDH staining on serial sections of aged Atg7f/f and Atg7-/- muscles (TA) shows an 
accumulation of abnormal mitochondria in Atg7-/- myofibers. (B) Electron microscopy images 
of EDL muscles from aged Atg7f/f and Atg7-/- mice show accumulation of abnormal 
mitochondria displaying alterations in size, cristae morphology and matrix density. (C) 
Measurement of mitochondrial membrane potential. Isolated FDB muscle fibres from adult 
Atg7f/f and Atg7-/- mice were loaded with TMRM, that accumulates in healthy mitochondria that 
are able to maintain membrane potential. Atg7-/- mitochondria dissipate membrane potential. 
TMRM staining was monitored in at least 20 fibers per group (** p<0.001). (D) Overall protein 
carbonylation of aged Atg7f/f and Atg7-/- muscles, revealed by Oxyblot. A representative 
immunoblot for carbonylated proteins is depicted on the left, and densitometric quantification 
of the carbonylated proteins is in the graph on the right. Aged Atg7-/- mice show higher ongoing 
protein carbonylation than Atg7f/f . (n=5, *p<0.05). 
 
Next we performed proteomic approach on carbonylated proteins to determine 
which proteins were oxidized in aged control compared to aged Atg7-/- mice. The 
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analyses revealed that mitochondrial and sarcomeric proteins, including actin, are 
indeed more carbonylated in aged Atg7-/- than controls. Since oxidative stress is 
believed to affect force generation, its enhancement might contribute to the ageing-
dependent weakness.  
Therefore, we studied this correlation at molecular level on single muscle cells in 
adult mice. Morphological and functional analyses on isolated single skinned fibres 
confirmed that autophagy-deficient muscle cells are more atrophic and generate less 
force (Figure 6A). Thus, not only the muscles become smaller but there is a general 
impairment in fibre contraction, which leads to profound weakness. Post-
translational modifications of contractile proteins induced by ROS could also affect 
the specific interaction between actin and myosin. In order to investigate that, first 
we checked the carbonylation level of actin and myosin. We found an increased 
carbonylation level of contractile proteins in Atg7-/- compared to control (Figure 
6B). Then we purified actin and myosin molecules and tested with an in vitro 
motility assay approach. Actin sliding velocity on both Myosin and HMM (a myosin 
proteolitic fraction able to move faster the actin filaments) of Atg7-/- mice was 
significantly slower compared to control (Figure 6C), confirming that autophagy 
block induces a functional alteration of contractile proteins. 
 
 
 
Fig. 6: (A) (B) In vitro analysis of isolated skinned muscle fibers from GCN muscles of Atg7f/f and 
Atg7-/-. (A) Single Atg7-/- myofibers are more atrophic and weaker (B) than Atg7f/f counterpart 
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(at least 20 fibers for each condition, * p<0.05). (C) Carbonylation of Actin (on the left) and 
Myosin (on the right) proteins, extracted from Atg7f/f and Atg7-/- GCN. Atg7-/- show higher 
carbonylation than Atg7f/f. (D) In vitro motility assay reveals reduced actin sliding velocity (Vf) 
on myosin (left panel) and HMM (right panel) extracted from adult Atg7-/- muscles in 
comparison with Atg7f/f. Reduced actin sliding velocity was statistically significant in Atg7-/- 
(n=4 per condition, *p<0.05) on both myosin and HMM.  
 
Since it has been demonstrated that oxidative stress might contribute to weakness 
and sarcopenia (Jang and Van Remmen, 2011), we wanted to test the role of 
oxidative stress in age-dependent muscle weakness. We treated adult animals (10 
months) for four weeks with Trolox, a cell-permeable water-soluble derivative of 
vitamin E with general antioxidant properties. The treatment successfully reduced 
the amount of total carbonylation on muscle protein extracts (Figure 7A). Then, we 
evaluated the effect of Trolox on mitochondria functionality. Anti-oxidant treatment 
blocked the oligomycin-dependent mitochondrial depolarization of Atg7 knockout 
animals (Figure 7B). Therefore, proteomic and functional assays showed that Trolox 
restored a normal mitochondrial function preventing the ROS-mediated damaging 
events on this organelle and on contractile proteins.  
 
 
 
Fig. 7: (A) Trolox treatment reduces the level of overall protein carbonylation in Atg7-/- muscles, 
thus abolishing the difference with Atg7f/f (n=4 mice per condition, * p<0.05). (B) Trolox 
treatment restores the ability of Atg7-/- mitochondria to maintain membrane potential (n>20 
fibers per group, ** p<0.001) 
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Then we asked which aspects of sarcopenia among atrophy, weakness and NMJ 
degeneration were affected by the blunting of oxidative stress. The treatment did 
not rescue myofibre size (Figure 8A) but reduced the drop of specific force in 
isolated Atg7-deficient myofibres (Figure 8B). Importantly, Trolox completely 
prevented carbonylation of purified myosin and actin (Figure 8C) and restored a 
normal acto-myosin interaction (Figure 8D). Concerning NMJ we found that 
inhibition of ROS in adult Atg7-/- mice only slightly reduced NMJ instability while did 
not ameliorate NMJ fragmentation (Figure 8E). In conclusion, these findings strongly 
suggest that ROS production directly affects acto-myosin interaction and force 
generation but shows a limited involvement on NMJ and no effect on atrophy. 
 
 
Fig. 8: (A) Trolox treatment does not affect fiber size in both Atg7f/f and Atg7-/- muscles (n=4 
mice per condition, * p<0.05). (B) In vitro isolated skinned fibers analysis: Trolox treatment 
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rescues the specific muscle force of isolated Atg7-/- myofibers, n=4 mice per condition, * p<0.05. 
(C) Trolox treatment reduces the level of actin (left panel) and myosin (right panel) protein 
carbonylation, in Atg7-/- muscles, thus abolishing the difference with Atg7f/f n=4 samples. (D) 
Trolox treatment rescues actin sliding velocity (Vf) in adult Atg7-/- muscles in in vitro motility 
assay, n=4 mice per condition, **p<0.01. (E) Confocal in vivo microscopy: Trolox treatment 
slightly reduces AChR turnover (data from at least 4 muscles per group, * p<0.05) but does not 
have any effect on NMJ fragmentation of adult Atg7f/f and Atg7-/- mice. 
 
3.4 AUTOPHAGY INHIBITION ALTERS THE RELEASE OF 
MUSCLE-DERIVED NEUROTROPHIC FACTORS 
 
Our last findings indicate that even if oxidative stress and ROS generations 
contribute to precocious ageing phenotype of Atg7-/- mice, other factors have to be 
involved in NMJ degeneration. It is well known that NMJ development and 
maintenance is mediated by neurotrophic factors, that are either secreted by the 
nerve itself, or either derived from the post-synaptic muscle fibres. So we focused on 
the idea that, in our model, autophagy inhibition blocked the release of some factors 
that could be important for NMJ. For this reason we screened by qRT-PCR the 
expression of several factors that are important for NMJ. Since the changes of NMJ in 
autophagy-deficient muscles already occurred in adult mice, we looked for 
neurotrophins that were less expressed in both adult and aged Atg7-/-mice. Among 
the different neurotrophins only Fibroblast Growth Factor Binding Protein 1 
(FGFBP1) was strongly down-regulated in both adult and aged autophagy deficient 
mice compared with control counterpart (Figure 9A). Similarly, when we tested the 
levels of FGFBP1 in humans we found a significant reduction of its expression in 
muscle biopsies of old sedentary subjects (Figure 9B). Importantly, regular exercise 
partially counteracted the downregulation of FGFBP1. This data well correlate with 
the morphological analyses that showed denervation and atrophy in old sedentary. 
These features were strongly attenuated in old sportsmen (Zampieri S et al. 
Manuscript in press), which also showed numerous fibre type groupings, a 
characteristic sign of re-innervation. 
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Fig. 9: (A) qRT-PCR screening of some neurotrophic factors involved in NMJ development 
reveals a suppression of FGFBP1 in adult and aged Atg7-/- muscles (n=4 mice per condition, 
**p<0.01). (B) qRT-PCR of FGFBP1 in muscle biopsies of young, old sedentary and senior 
sportsmen, n=4 young, n=4 old sedentary and n=9 senior sportsmen, * p<0.05.  
 
To further get insight the role of autophagy in age-related NMJ alterations we used 
the inducible muscle specific Atg7 knockout mice that we have recently generated 
(Masiero et al., 2009). Atg7 gene was acutely deleted in 22 months old mice and 
mice were sacrificed 4 months later. Western blots for p62 and LC3 revealed that 
autophagy was successfully blocked in aged mice (Figure 10A). Then we proved that 
acute autophagy block was sufficient to induce an atrophic and myophatic 
phenotype, in fact we observed a trend concerning: reduction in fibres CSA and an 
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increased number of central-nucleated fibres (Figure 10B-C). Next we monitored 
NMJ to determine whether few months of autophagy inhibition in old mice were 
sufficient to destabilize muscle-nerve interaction. We found an up-regulation of 
MuSK and an increased number of NCAM positive fibres (Figure 10D-E). qRT-PCR 
revealed a suppression of FGFBP1 in muscles of inducible Atg7-/- (Figure 10D right 
panel). Importantly, acute inhibition of autophagy in aged mice caused a significant 
loss of MuSK on the myofiber plasma membrane and a concomitant enrichment of 
internalised MuSK protein (Figure 10F). 
 
 
Fig. 10: (A) Immunoblotting for Atg7, LC3 and p62 proteins on muscle extracts from 24 months 
old inducible Atg7-/- female mice. Three months after the tamoxifen treatment, skeletal muscles 
were collected and analysed. (B) Acute inhibition of autophagy in old mice induces muscle 
degeneration. Quantification of CSA of myofibers in TA muscles of aged inducible Atg7-/- and 
Atg7f/f mice. Values are mean +/- s.e.m., at least 5 muscles per group were analysed, *p<0.05. (C) 
Quantification of center-nucleated myofibers in TA of inducible Atg7-/-. (n> 5 for each group, 
**p<0.01).(D) Expression levels of MuSK (left) and FGFBP1 (right) after acute inhibition of Atg7 
in old mice. MuSK is up-regulated while FGFBP1 is down-regulated in aged inducible Atg7-/- 
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muscles (*p<0.05, n>5). (E) Quantification of NCAM-positive fibers. Values were normalized for 
the total number of myofibers in muscle section (at least 5 muscles per group were analysed, 
*p<0.05). Acute inhibition of Atg7 in aged female mice increases the number of denervated N-
CAM positive fibers when compared to age-matched controls (at least 4 muscles per group were 
analysed, *p<0.05). (F) Acute inhibition of autophagy in aged mice led to an increased amount 
of diffused MuSK staining; at least 4 muscles per group were analysed ***p<0.001. 
 
The next step was to understand the role of FGFBP1. FGFBP1 is a secreted factor 
that interacts and potentiates the bioactivity of FGF-7, FGF-10, and FGF-22 family 
members. Because FGF-7, FGF-10, and FGF-22 are muscle-derived regulators that 
promote pre-synaptic differentiation at the NMJ (Jang and Van Remmen, 2011; 
Williams et al., 2009), we hypothesized that alterations of FGFBP1 expression might 
affect NMJ maintenance. To address this point we performed both loss and gain of 
function approaches. First we mimicked autophagy-deficient muscle by knocking 
down FGFBP1 in adult muscles of control mice. Four different shRNAs were tested 
to specifically reduce FGFBP1 protein levels. C2C12 cell were transfected for 24 
hours with the different oligos, and then western blot was performed on C2C12 
protein extract. Two of them efficiently knocked down FGFBP1 (Figure 11A). For in 
vivo transfection experiments we used bicistronic vectors that simultaneously 
encode shRNAs and GFP. Therefore, detection of GFP fluorescence allows us to 
monitor the efficiency of transfection and the changes that occur on NMJ of 
transfected fibres. We then monitored that oligos 3 efficiently reduced FGFBP1 
transcript in vivo, also on isolated single fibres (Figure 11B). 
 
 
Fig. 11: (A) Four different shRNAs were tested against FGFBP1 expression. Western blot of 
C2C12 protein extract revealed that shRNA 3 and 4 successfully blocked FGFBP1 expression.(B) 
In vivo transfection of FDB fibers confermed that oligo 3 was able to reduce FGFBP1 expression. 
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We then transfected shRNAs into adult TA muscles for two weeks. In order to 
evaluate NMJ morphology and stability, after 4 days from transfection we injected α-
bungarotoxin (BGT) coupled to AlexaFluor647 to label old acetylcholine receptors 
and 10 days later we injected BGTAF555 to label new receptors. After 14 days from 
transfection old receptors, new receptors, and synapse morphologies were 
monitored using confocal in vivo microscopy. Interestingly, knockdown of FGFBP1 in 
vivo induced significant changes in NMJ morphology, increasing NMJ instability and 
fragmentation (Figure 12A). Similar to Atg7-/-, AChR clusters were fragmented and 
showed a higher turnover than those in myofibres expressing scramble oligos. 
Moreover, we quantified the number of NCAM positive fibres and it was significantly 
increased in muscles where FGFBP1 was down-regulated (Figure 12B).  
 
 
 
Fig. 12: (A) AChR turnover and NMJ fragmentation increase in control mice transfected with 
shRNA-3 against FGFBP1, * p<0.05. (B) Quantification of NCAM-positive fibers in control and in 
FGFBP1 knocked down fibers. Values were normalized for the total number of myofibers in 
muscle section (n=9 muscles per group were analysed, *p<0.05) 
 
Then we decided to rescue FGFBP1 expression in Atg7-/- mice and monitor whether 
this could reduce the changes in NMJ and the number of denervated fibres. Adult TA 
muscles of Atg7-/- and control mice were co-transfected with vectors encoding 
FGFBP1 and GFP. Over-expression of FGFBP1 in autophagy-deficient muscle 
significantly reduced to control level the number of NCAM-positive fibres as the 
level of AChR turnover (Figure 13A-C). Moreover, MuSK localization was 
ameliorated after FGFBP1 over-expression (Figure 13D), suggesting that FGFBP1 
elicited a protective action on NMJ.  
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Fig. 13: (A) Overexpression of FGFBP1in Atg7-/- reduces the number of NCAM positive fibers. 
Muscles of Atg7 f/f and Atg7 -/- were co-transfected in vivo with plasmids coding for FGFBP1 and 
GFP (green); fourteen days later NCAM expression (red) was evaluated. (B)The number of N-
CAM positive fibers was quantified and normalized with the total number of myofibers per 
muscle section (at least four muscle for each condition have been analysed. ** p>0.001). (C) 
Confocal in vivo microscopy: FGFBP1 expression for two weeks greatly reduces AChR turnover 
(* p<0.05) but does not ameliorate NMJ fragmentation of Atg7-/- mice. (D) Expression of 
FGFBP1 in Atg7-/- significantly restored normal MuSK localization; n=4 Atg7f/f and n=16 Atg7-/- 
muscles per group were analysed *p<0.05. 
 
Therefore, FGFBP1 is a muscle-derived synaptic organizing factor that is required 
for NMJ maintenance. 
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3.5 DEFINING THE LINK BETWEEN AUTOPHAGY 
INHIBITION AND FGFBP1 ALTERATION 
 
Since MuSK is a critical kinase that affects pathways involved in NMJ stability and 
since autophagy impairment resulted in abnormal internalization of AChR and 
MuSK, we reasoned that the downregulation of FGFBP1 is a consequence of MuSK 
inhibition. To mimic such situation we knocked down MuSK in adult tibialis anterior 
(TA) muscles, in vivo, and monitored FGFBP1 expression. We designed functional 
shRNAs against MuSK and transfected them in vivo for fourteen days. We confirmed 
a significant reduction of MuSK that led to downregulation of FGFBP1 (Figure 14A). 
Consistent to the data of FGFBP1 downregulation, acute inhibition of MuSK in adult 
control mice caused a significant increase of denervated NCAM-positive fibers 
(Figure 14B). These results indicated that MuSK impairment determines the 
suppression of FGFBP1 expression causing NMJ instability and myofiber 
denervation. 
 
 
 
 Fig. 14: (A) qRT-PCR of MuSK in TA muscles transfected with shRNA against MuSK or scramble. 
MuSK was efficiently downregulated (at least 3 muscles per condition were analysed, *p<0.05). 
qRT-PCR of FGFBP1 in TA muscles that were transfected with shRNAs against MuSK or 
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scramble (at least 3 muscles per condition were analyzed, *p<0.05). (B) Knockdown of MuSK 
increases the number of denervated N-CAM positive fibers when compared to age-matched 
controls (at least 3 muscles per group were analysed, *p<0.05). 
  
PART II 
 
3.6 AUTOPHAGY IS NOT REQUIRED TO SUSTAIN 
CONTRACTIONS DURING PHYSICAL ACTIVITY 
 
Physical activity has been demonstrated to improve glucose and lipid homeostasis, 
maintain muscle mass and delay ageing. Moreover it has been reported that 
autophagy is activated upon exercise, but is still unclear whether the beneficial 
effects of exercise are due to autophagy induction. For this reason it is essential to 
define the link between autophagy and exercise. Previous works have reported 
controversial data, so it would be very important clarify the role of specific skeletal 
muscle autophagy during physical activity.  
To address the role of skeletal muscle autophagy during physical activity we acutely 
deleted the Atg7 gene in adult animals (3 months old and sacrificed at 7 months ) by 
treating inducible muscle-specific Atg7 knockout mice with tamoxifen (Atg7HSA-/-) 
(Masiero et al., 2009). This inducible model was used in order to minimize the 
chance of any adaptations and compensations that occur with constitutive or 
conditional deletion of genes embryonically or at a very young age. First, we verified 
by western blot that block of autophagy had occurred, indeed after Tamoxifen 
treatment both p62 and non lipidated form of LC3 (LC3-I) did accumulate. 
In order to investigate whether the acute block of autophagy in muscle affects 
exercise performance, control and inducible Atg7-/- mice performed exercise on a 
treadmill. We used a standard concentric exercise protocol while monitoring the 
maximum distance ran to exhaustion. Surprisingly, we did not find any significant 
difference in running capacity between controls and Atg7-/-. Even looking at gender 
specific results, no differences were revealed between the Atg7f/f and Atg7-/- (Figure 
98 
 
15), suggesting that autophagy is not required to sustain muscle contraction during 
physical activity. 
 
 
Fig. 15: (A) Representative western blot analyse, it confirmed p62 and LC3-I accumulation in 
Atg7-/- after Tamoxifen treatment. (B) No differences observed in the maximal running distance 
during concentric exercise between control and Atg7-/-(at least 10 mice per group were 
analysed, *p<0.05); this result was confirmed evaluating also the gender-specific issue, thus 
females (C) and males (D).   
  
3.7 AUTOPHAGY IS IMPORTANT TO SUSTAIN PHYSICAL 
ACTIVITY THAT PROVOKE DAMAGING CONTRACTIONS 
 
Since autophagy is important for effective protein and organelle turnover as well as 
for survival under cellular stress, we tested whether autophagy could have a role in 
repairing muscle after damaging contraction. To address this, we performed a 
downhill running exercise to induce damaging eccentric contraction in Atg7f/f and 
Atg7-/- animals while recording maximal running distance achieved. 
We confirmed that autophagy was induced upon exercise in control animals, as 
indicated by the lipidation of LC3 and a decrease in p62 in the muscle of Atg7f/f. 
Conversely, Atg7-/- maintained their high levels of LC3-I and p62 protein, confirming 
the efficient inhibition of autophagy (Figure 16A). 
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On average autophagy-deficient mice ran less than wild type. However, when we 
took gender into consideration we found that Atg7 deficient females but not males 
ran less than their wild type counterparts (Figure 16B). Next, we investigated 
whether this result was maintained after prolonged physical activity, that induce an 
additive detrimental effect on muscle performance, as a consequence of cumulative 
damage. So, control and Atg7-/- mice performed repeated bouts of eccentric exercise 
to exhaustion for three consecutive days, that generate damaging eccentric 
contraction. As expected, both genotypes performed progressively worse over time 
(Figure 16C). However, autophagy-deficient females ran less than their littermate 
controls on all three days of exercise. 
Next, we focused on the reason of this reduced performance, so we looked first at 
morphological alterations. H&E did not reveal any structural impairment or 
inflammation (Figure 16D). To assess whether eccentric contraction had caused 
damage to plasma membranes we stained myofibres for serum immunoglobulins. 
However, we did not find any positive staining inside myofibres, confirming that 
plasma membrane integrity was retained after eccentric contraction in both 
genotypes (Figure 16E), thus suggesting that autophagy knockout weakness was not 
due to major structural alterations.  
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Fig. 16: (A) A representative western blot showed decrease of p62 and increase of LC3-II upon 
exercise in control animals, quantification analyses are reported on the right (n>5 for each 
group) , moreover the same western blot confirmed p62 and LC3-I accumulation in Atg7-/- after 
Tamoxifen treatment. (B) Maximal running distance during eccentric exercise between control 
and Atg7-/- (at least 10 mice per group were analysed, *p<0.05), Atg7-/- females (on the left) run 
significantly less than controls, no differences observed between males (on the right; (C) 
Maximal running distance reported for each day of exercise, both genotypes performed 
progressively worse over time. (D-E) H&E and IgG staining did not reveal any structural 
impairment or inflammation. 
 
A 
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3.8 AUTOPHAGY IS NOT REQUIRED FOR AMPK ACTIVATION 
AND FOR EXERCISE-MEDIATED GLUCOSE UPTAKE 
 
It has been reported that exercise-induced autophagy plays a critical role in AMPK 
activation and glucose homeostasis. It is therefore conceivable that the energy 
imbalance caused by exercise may explain the exercise intolerance observed in 
autophagy-deficient females. We monitored phosphorylation the level of AMPK and 
its direct downstream target ACC but no significant differences were observed 
between Atg7f/f and Atg7-/- (Figure 17). 
 
 
 
Fig. 17: (A) A representative western blot showed no differences in P-AMPK and P-ACC between 
control and Atg7-/- after exercise. (B) Quantification analyses are reported as ratio between P-
AMPK/Total-AMPK and P-ACC/GAPDH (n=4 for each group). 
 
To further investigate the presence of a possible energy imbalance, we measured 
blood levels of glucose and lactate in males (Figure 18A) and females (Figure 18B). 
After exercise, blood glucose was reduced along with a concomitant increase in 
blood lactate. Interestingly this metabolic profile was unaltered by the block in 
autophagy, as free fatty acid and cheton bodies content. 
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Fig. 18: Blood metabolites levels quantification in females (A) and males (B), no major 
differences were observed between controls and Atg7-/- before and after exercise (n>5 for each 
group, *p<0.05, ***p<0.001). 
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Accordingly, we did not find any significant changes in Glut4 expression or 
localization in Atg7-/- myofibres (data not shown) when compared to controls. 
Moreover, PAS and OIL RED staining did not reveal any glycogen or lipid 
accumulation in Atg7-/- mice (data not shown).  
Altogether, these data suggest that muscle autophagy is not required for metabolic 
regulation during exercise, being unaltered both AMPK activation as well as glucose 
and lipid utilization. 
 
3.9 AUTOPHAGY IS IMPORTANT TO PREVENT 
ACCUMULATION OF DYSFUNCTIONAL MITOCHONDRIA 
DURING DAMAGING CONTRACTION 
 
Since autophagy is important for organelle quality control, we tested whether 
mitochondrial homeostasis was altered in wild type and autophagy deficient 
animals following exercise. Interestingly, flexor digitorum brevis (FDB) myofibers 
isolated from Atg7-/- showed a significant increase in depolarized mitochondria 
following treatment with the F1F0-ATPase blocker, oligomycin (Figure 19A). 
Interestingly, while eccentric exercise did not affect mitochondrial membrane 
potential in wild type animals, it exacerbated the percentage of depolarised fibres in 
Atg7-/- mice (Figure 19B, C). These alterations in mitochondrial membrane potential 
correlated with the impairment in physical performance.  
Males lacking autophagy also demonstrated an increase in the number of fibres with 
depolarized mitochondria, however, to a lesser extent than females. Eccentric 
exercise did not alter the ability of Atg7f/f mitochondria to respond to exercise and 
indeed their mitochondria showed a slight hyperpolarization immediately after 
exercise which was completely restored to normal 3 days later (data not shown). 
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Fig. 19: Mitochondria membrane potential measurements in control and Atg7-/- females: before 
exercise (A), immediately after exercise (B), three days after exercise (C). While mitochondria of 
control mice are able to maintain their functionality upon exercise, Atg7 -/- dissipate the 
potential, worsening the percentage of depolarized fibres with time (n>10 fibres for each 
group). 
 
During contraction, skeletal muscle is a major source of ROS, as well as one of the 
main targets (Powers and Jackson, 2008). Since mitochondria are the main source 
and effectors of ROS in the cell it is feasible that oxidative stress may play a role in 
the observed results. Therefore, we measured total protein carbonylation in 
exercised muscles. As expected, Atg7 null muscles showed more carbonylated 
proteins than exercise-matched controls (Figure 20A). 
To further investigate the source of ROS in these mice we used a mitochondrial 
targeted ROS-sensor (Dooley et al., 2004). The sensor was transfected in adult FDB 
muscles and 7 days later mice were exercised and sacrificed. FDB fibres were 
isolated and fluorescence changes were monitored and quantified. Atg7-/- mice 
produced more ROS compared to controls and this increase become significant after 
exercise (Figure 20B). Moreover, it is interesting to underline that after exercise ROS 
level in control mice was similar to the level present in Atg7-/- mice before exercise. 
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This result confirmed that dysfunctional mitochondria are the source of ROS that 
generate an oxidative stress in Atg7-/-. 
 
 
 
Fig. 20: (A) Oxiblot analysis showed an increased level of carbonylated proteins in Atg7-/- 
compared to controls, as confirmed by quantification analyses (on the right. (B) ROS 
production measurements supported the evidence that in Atg7-/- there is an high ongoing 
oxidative stress compared to control mice and this difference increases after exercise. (n=5 for 
each group *p<0.05).   
 
Therefore, acute inhibition of autophagy led to accumulation of dysfunctional 
mitochondria, increased oxidative stress and reduced physical performance during 
eccentric contraction. 
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3.10 ANTI-OXIDANT TREATMENT DID NOT AMELIORATE 
THE PHYSICAL PERFORMANCE OF ATG7 KNOCKOUT 
BUT BLOCKED AUTOPHAGY IN CONTROLS WORSENING 
MITOCHONDRIAL FUNCTION AND RUNNING CAPACITY 
 
Excessive oxidative stress has been documented to impair muscle function, which 
could potentially explain the reduced physical performance of Atg7-/- mice. 
(Peternelj and Coombes, 2011; Powers and Jackson, 2008). 
In order to evaluate whether reducing oxidative stress could ameliorate their 
physical performance, we treated female Atg7-/- and control mice with the 
antioxidant N-Acetyl-Cysteine (NAC) for 6 weeks. and then subjected them to 
eccentric exercise. Surprisingly, NAC treatment severely impaired performance of 
control but did not elicit any benefit in inducible Atg7-/- mice (Figure 21). Indeed, the 
difference in the running distance between control and Atg7-/- mice was abolished at 
both one and three days of exercise.  
 
 
 
Fig. 21: The maximal running distance of females control mice decreased after NAC treatment 
from the first day (on the left) till the end (on the right) of the protocol. No difference between 
maximal running distance between control and Atg7-/- mice (n>5 for each group *p<0.05, 
***p<0.001). 
 
We first checked whether NAC treatment affected general protein carbonylation. 
The level of carbonylated proteins was reduced both in control and Atg7-/- mice after 
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the treatment, suggesting that NAC preserved control mice from ROS and reduced 
the ongoing oxidative stress present in Atg7-/- mice (Figure 22). 
 
 
 
Fig. 22: (A) Oxiblot analysis showed an increased level of carbonylated proteins in Atg7-/- 
compared to controls, as confirmed by quantification analyses (B). Oxidative stress was 
significantly reduced in Atg7-/- mice after NAC treatment (n=3 for each group, *p<0.05). 
 
Then, we wanted to further investigate the unexpected effect of NAC in control mice, 
so we monitored mitochondrial function in control mice before and after exercise. 
Interestingly, NAC treatment resulted in impaired ability to retain mitochondrial 
membrane potential in controls (Figure 23). In fact, NAC treated control mice 
exhibited a percentage of depolarized fibres prior to exercise that was similar to that 
of Atg7-/- mice (Figure 23A). Interestingly, exercise slightly reduced the amount of 
fibres with abnormal mitochondria from 62,5% to 42,1%. Therefore, exercise 
appears to have differential effects on mitochondrial membrane potential, where it 
exacerbates depolarization in Atg7-/- (compare with figure 19B), while improving 
that of NAC treated Atg7f/f, respectively (Figure 23B). 
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Fig. 23: Mitochondria membrane potential analyses after NAC treatment, before (A)and after 
(B) exercise. (n>15 fibres for each group). After NAC treatment, control and Atg7-/- mice showed 
similar level of depolarized fibres, that ameliorates after exercise in both conditions. 
 
For this reason we further investigated the signalling events mediating this 
seemingly differential regulation.  
We confirmed that even if AMPK is heavily implicated in exercise autophagy and 
mitochondrial regulation, in this case it is not the metabolic link. In fact, we 
observed no difference in exercise triggered AMPK and ACC phosphorylation 
between control and inducible Atg7-/- mice, indicating that AMPK is not responsible 
for the alteration in mitochondrial function reported (Figure 24). 
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Fig. 24: (A) Representative western blot and quantification analyses (B) of phosphorylation 
levels of AMPK and ACC confirmed that there are no major differences between control and 
Atg7-/- mice, upon exercise, after NAC treatment (n=5 for each group, *p<0.05).  
 
We finished the metabolic analyses evaluating blood metabolites after NAC in both 
control and Atg7-/- mice, but again we did not observe significant changes between 
genotypes before and after exercise (data not shown), confirming that this is not a 
metabolic issue.  
 
In order to further investigate this point we tested a different anti-oxidant, called 
Mito-TEMPO, that acts specifically on mitochondria. Control and Atg7-/- mice were 
treated with Mito-TEMPO for 7 days and then performed the same protocol of 3 
days eccentric exercise.  
Analyzing the maximal distance run, we obtained the same results observed with 
the previous treatment with NAC. Also in this case, Mito-TEMPO treated control 
mice run less than no treated mice, showing similar distance than Atg7-/- mice 
treated with Mito-TEMPO (Figure 25). 
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Fig. 25: The maximal running distance of females control mice decreased after NAC treatment 
from the first day (on the left) till the end (on the right) of the protocol. No difference between 
maximal running distance between treated control and Atg7-/- mice (n>3 for each group, 
*p<0.05, **p<0.01). 
 
Moreover, we analyzed mitochondria functionality and found that again 
mitochondria of control mice treated with Mito-TEMPO were dysfunctional in basal 
condition, as the Atg7-/- mice (Figure 26).  
 
 
Fig. 26: Mitochondria membrane potential analyses after Mito-TEMPO treatment, before (A) 
and after (B) exercise. After Mito-TEMPO treatment, control and Atg7-/- mice showed similar 
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level of depolarized fibres, that ameliorates after exercise in both conditions (n>15 fibres for 
each group). 
 
At this point we focused on the common results found with different anti-oxidant to 
understand the reduced performance of control treated mice.  
It has been reported that treatment with anti-oxidant, such as NAC, impairs basal 
autophagy process in control animals (Underwood et al., 2010), so we wondered 
whether the reduced physical performance of NAC treated control mice was due to 
an impaired autophagy activation.  
We monitored LC3 lipidation, as the major marker of autophagy, and the level of p62 
protein in control and treated mice, before and after exercise. We observed that NAC 
treated control mice display a reduced LC3-II level, both in basal condition and upon 
exercise, compared to no treated control mice (Figure 27A-B). Moreover, p62 
accumulates in NAC treated control mice in basal condition, indicating that NAC 
treatment reduced autophagy (Figure 27C). Upon exercise, we observed reduced 
level of p62, both in no treated and treated control mice, suggesting that exercise 
promotes autophagy induction even if it is reduced by NAC treatment. 
 
Fig. 27: Representative western blot(A) and quantification analyses of LC3-II (B) and p62 (C) in 
no- and NAC treated control mice, before and after exercise. NAC treatment causes autophagy 
reduction (n=5 for each group, *p<0.05, ***p<0.001).  
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These findings suggest that impaired physical performance of NAC treated control 
mice was due to a reduction in autophagy process, mediated by NAC treatment.  
 
Altogether, these findings underline the critical role of autophagy in the 
maintenance of proper mitochondrial function. Moreover, we highlight an important 
physiological role of oxidative stress for basal autophagy regulation in skeletal 
muscle. 
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4. DISCUSSION 
 
In this work, by using muscle specific autophagy-deficient (Atg7-/-), we investigated 
the role of autophagy in skeletal muscle during ageing and exercise. We analyzed 
how decreased autophagy is related to ageing and the reason why autophagy 
reactivation can lead to ameliorated ageing features and increased lifespan.  
 
PART I 
 
In the first part of the work, we studied the role of autophagy during ageing in 
muscle tissue. Our results highlight two important functions of autophagy in 
sarcopenia, in fact it is responsible for the removal of damaged mitochondria that 
produce ROS, and for the signalling that induces the release of the neurotrophic 
factor FGFBP1 to maintain NMJ and muscle–nerve interaction.  
Ageing leads to the functional degeneration of tissues and this is mainly due to 
accumulation of damaged DNA, proteins and organelles. Autophagy is a catabolic 
process essential for the maintenance of tissue homeostasis. It is responsible for the 
removal of dysfunctional proteins that are prone to aggregate, and for proper 
organelle turnover, such as mitochondria, in order to reduce ROS production and 
preserve DNA stability (Sandri, 2010). 
Due to these actions and to the fact that autophagy declines with age, there is 
consensus in considering autophagy as an anti- ageing system. Indeed, genetic 
evidences in flies and worms sustain this concept but this indication is still lacking in 
mammals (Lee et al., 2010b; Rubinsztein et al., 2011; Simonsen et al., 2008; Madeo 
et al., 2010).  
For what concerns mammals, there is a more complicated scenario, because 
autophagy knockout mice die at newborn stage due to a general energy failure 
(Kuma et al., 2004) and most of the tissue specific knockouts (e.g. in brain or 
heart)(Hara et al., 2006; Komatsu et al., 2006; Nakai et al., 2007) show severe organ 
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dysfunctions that precludes ageing studies. For this reason the link between 
autophagy and ageing is still lacking in mammals.  
Our conditional model of muscle-specific autophagy deficiency allowed us to analyse 
the role of autophagy in muscles of adult and aged animal. Our findings support the 
notion that autophagy failure contributes to ageing. Adult Atg7-/- mice are 
characterized by mitochondrial dysfunction, oxidative stress, weakness, atrophy and 
loss of innervations; those are typical features of the ageing state, thus suggesting 
that autophagy-deficiency leads to premature ageing. Moreover, we found that 
altogether these events did shorten the lifespan of autophagy-deficient animals.  
Ageing is a multisystemic disorder that affects multiple organs leading to alterations 
of metabolism and tissue function. The post-mitotic tissues such as brain, heart and 
skeletal muscle are the most susceptible to age-related diseases and precocious 
ageing when some dysfunction occurs. Interestingly, among the different age-related 
features, only one is conserved in several species, such as C.elegans, Drosophila, and 
mammals, including humans, that is the loss of muscle force. Therefore, muscle is a 
proper tissue that can be used to investigate ageing mechanisms. Moreover, muscles 
play an important role in the regulation of glucose, lipids and therefore in the 
general control of metabolism. Recent studies in Drosophila sustained the important 
role of muscle in healthy ageing. It has been shown that the over-expression of FoxO 
transcription factor, (that leads to autophagy activation), in the muscles of flies, 
preserves muscle function and increases longevity (Demontis and Perrimon, 2010), 
decreasing the accumulation of protein aggregates also in other tissues. On the 
contrary the over-expression of FoxO in adipose tissue, did not induce any changes. 
These results confirm that maintenance of a normal autophagy level in skeletal 
muscle, is sufficient to induce positively effects on whole-body metabolism, 
suggesting an important regulatory role for muscle tissue (Demontis and Perrimon, 
2010).  
Muscle-specific autophagy deficient mice allowed us to dissect the role of autophagy 
during ageing. Our findings support the notion that autophagy is critical to prevent 
sarcopenia. Indeed autophagy inhibition is sufficient to trigger a precocious ageing 
state in adult mice. It has been shown that oxidative stress increases during ageing, 
because of a reduction in autophagy flux and accumulation of dysfunctional 
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mitochondria. Since mitochondria are the main producers of ROS, dysfunctional 
mitochondria are thought to play a key role in decline of muscle function. At old age, 
a significant proportion of the mitochondria are abnormally enlarged, more rounded 
in shape and display vacuolization in the matrix and shorter christae (Peterson et al., 
2012). We found that block of autophagy leads to accumulation of mitochondria 
with altered morphology and function. Accordingly, in the previous work it was 
showed that energy-stress sensor, AMPK, is activated in Atg7-/- muscles (Masiero et 
al., 2009). Importantly, we showed that mitochondrial dysfunction can be reversed 
by inhibiting ROS production through the anti-oxidant Trolox. This finding is 
consistent with a recent report that showed amelioration of age-related deficit, 
including mitochondrial function, by expressing a mitochondrial-targeted human 
catalase (Lee et al., 2010a). An higher production of ROS, leads to increased protein 
carbonylation, that mainly affects mitochondrial and structural proteins, such as 
actin and myosin. This contributes to impaired muscle contraction and weakness, 
caused by an altered actin/myosin interaction and a reduction in force generation. 
Trolox treatment reverted both protein oxidation and actin sliding properties, 
ultimately ameliorating muscle force. It is well established that changes in muscle 
mass and strength tend to be dissociated in elderly persons, being the decline of 
muscle strength three times faster than the decrease of muscle mass (Peterson et al., 
2012). This notion suggests that alteration in the quality of contractile proteins 
plays critical role during age-related decrease of muscle force. Importantly, while 
anti-oxidant ameliorates acto/myosin functionality, it does not protect from muscle 
atrophy. However we cannot exclude that extending Trolox treatment would 
counteract muscle atrophy as well. Autophagy impairment also causes instability 
and degeneration of NMJ. Previous studies reported that mitochondrial ROS 
production may contribute to NMJ instability (Dobrowolny et al., 2008; Jang et al., 
2012; Jang et al., 2010). But in our hands anti-oxidant treatment only slightly 
ameliorated NMJ stability of autophagy deficient mice, with no effect on 
fragmentation suggesting that other players were necessarily involved in NMJ 
maintenance. Indeed muscle tissue itself plays an important role in the signalling for 
NMJ development and maintenance (Johnson-Venkatesh and Umemori, 2010). In 
particular, molecules are secreted retrogradely from muscle to nerve, thus affecting 
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motor neuron survival, growth and maintenance (Dobrowolny et al., 2005; 
Funakoshi et al., 1995). We found that FGFBP1 is required for NMJ maintenance and 
that a normal autophagic flux is critical for its correct regulation. Knocking down 
FGFBP1 expression for 14 days in control muscles was sufficient to trigger 
fragmentation of NMJs and to increase AChR turnover. Moreover, these effects 
appear after only 2 weeks of FGFBP1 inhibition. Prolonged FGFBP1 perturbation 
might even worsen NMJ instability and fragmentation. In the opposite situation, 
when we over-expressed FGFBP1 in Atg7-/- mice we observed an ameliorated NMJ 
stability and rescue in the number of NCAM positive fibres, thus confirming that 
FGFBP1 is a muscle-derived synaptic organizing factor that is required for NMJ 
maintenance. 
The alteration of FGFBP1 expression is a consequence of the impairment of 
endocytic trafficking that impacts on AChR cluster and MuSK activity on 
downstream signalling. In fact surface expression of MuSK, a kinase that affects a 
plethora of signalling pathways that are important for NMJ stability, is regulated by 
the endocytic pathway (Punga and Ruegg, 2012). MuSK does not properly localize at 
the NMJ in Atg7 knockout, being internalized instead of being at the surface of the 
myofibre. However, it was re-localized at the NMJ when FGFBP1 was over-expressed 
in Atg7-/- mice. 
Our data strongly support the concept that autophagy, in a post-mitotic tissue, is 
required for healthy ageing being critical for the correct interplay between muscle 
and nerve and for the quality-control of mitochondria. Moreover we have evidences 
to believe that the beneficial effects of caloric restriction and exercise on ageing are 
a consequence of autophagy reactivation. Future works will investigate the link 
between autophagy inhibition, altered expression of FGFBP1 and MuSK. 
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PART II 
 
In the second part of the work, we investigated the connection between autophagy 
and physical exercise.  
We found that autophagy is required for healthy ageing. Lifestyle adaptations, in 
particular caloric restriction and physical activity contributes to increase lifespan 
ameliorating some ageing features (Melov et al., 2007; Fontana et al., 2010; Sandri et 
al., 2013). In particular, we analyzed human biopsies of young, aged sedentary 
subjects or senior sportsmen. We confirmed that autophagy is reduced with ageing, 
but upon exercise it is reactivated also in elderly. So it is important to understand 
the role of autophagy during physical activity, and to investigate whether the 
beneficial effects of exercise (that are also visible in aged people) are directly due to 
autophagy reactivation.  
Autophagy is activated upon exercise in several tissues, in particular it has been 
shown that acute bout of exercise activates autophagosome formation in skeletal 
muscles (Grumati et al., 2010; Grumati et al., 2011a; Grumati et al., 2011b; He et al., 
2012; Rubinsztein et al., 2011; Wohlgemuth et al., 2010). It has previously reported 
that autophagy is required for proper energy provision and glucose homeostasis 
during muscle contraction potentially through AMPK activation and its downstream 
targets (He et al., 2012). However, another study reached the opposite conclusion 
indicating that autophagy inhibition results in an improved blood glucose profile 
(Kim et al., 2013). Therefore, up to now there is no general consensus about the 
metabolic impact of autophagy during exercise, whether this effect is cell-
autonomous and the mechanism underlying has not been fully understood yet. In 
order to address this issue we used inducible muscle-specific autophagy knockout 
mice, that were recently generated in our laboratory (Masiero et al., 2009). In these 
mice a muscle-specific acute deletion of the Atg7 gene was induced upon Tamoxifen 
treatment just before exercise. We used this model to avoid any possible 
compensation mechanism, that occur in conditional models.  
We observed that block of autophagy in skeletal muscle did not impact on physical 
performance, glucose homeostasis or AMPK activation in our mice. Accordingly, a 
recent report where heterozygous mice for BECLIN1 were subjected to exercise also 
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found no differences in running capacity, providing further evidence that autophagy 
is not required during an acute bout of exercise (Safdar et al., 2011). The same study 
also demonstrated that the absence of exercise-induced autophagy results in a lack 
of exercise training-induced adaptations; thus suggesting that autophagy is required 
for muscle adaptations to chronic exercise which need mitochondrial turnover and 
remodelling (Safdar et al., 2011). So we wondered whether reduced performance 
was caused by impaired mitochondria functionality. Our data, indeed, support the 
idea that autophagy is critical for removing dysfunctional mitochondria during 
damaging contraction, and in fact the absence of autophagy leads to reduced 
running performance mainly due to increased ROS production and accumulation of 
dysfunctional mitochondria. Interestingly, this effect is gender specific being females 
more affected than males. These data are in line with the concept that females are 
more prone to muscle wasting during catabolic conditions. Moreover, one possibility 
could be that impairment in protein and organelle turnover might manifest more 
rapidly in females than in males, as it is known that in different tissues, such as 
brown adipose tissue, or mechanisms, such as oxidative stress response and 
mitochondria biogenesis, there are sex-dependent differences. (Nadal-casellas et al., 
2013; Huges and Hekimi, 2011). Nevertheless it is plausible that different exercise 
regimens or a more chronic autophagy inhibition may unravel alterations in muscle 
performance in males as well. Further research into gender difference is required in 
order to discern the mechanisms responsible for male protection and female 
predisposition.  
We wondered then whether reduction of oxidative stress could ameliorate physical 
performance of Atg7-/- mice. The chronic use of the antioxidant N-acetyl-cysteine did 
not ameliorate Atg7-/- performance, but on the contrary impaired the one of control 
animals. Moreover control mice treated with NAC showed a decreased basal and 
exercise-induced autophagy level. This result suggest that a basal level of ROS is 
necessary as signal to maintain redox homeostasis and autophagy activation 
mechanisms. Other works reported that ‘physiological ROS’ are important to 
mediate autophagy activation, thus maintaining tissue homeostasis (Underwood et 
al., 2010; Owusu-Ansah et al., 2013). Moreover, our findings correlate with the 
notion that anti-oxidants are detrimental for exercise-induced benefits, that has 
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already been reported in humans, although the mechanisms remain unclear (Ristow 
et al., 2011). We did not found significant changes in AMPK activation nor in blood 
metabolites that could explain the reduced physical performance. Moreover these 
data were confirmed when we acutely treated mice with a mitochondria-specific 
antioxidant.  
Since we did not observed metabolic changes, we thought that one possible 
explanation could involve mitochondria-derived metabolites, which play an 
important role in signalling and could therefore impinge on cellular adaptations to 
stress. In our case, dysfunctional mitochondria can release factors that damage 
muscle tissue or, on the contrary, mitochondria impairment can lead to lack of 
certain important secreted factors. For instance, alpha-ketoglutarate-derived 
glutamine has been found to inhibit mTOR activity and activate autophagy (van der 
Vos et al., 2012). Importantly a recent work reported that impaired mitochondrial 
function in muscle specific Atg7 knockouts is protective from diet-induced obesity 
due to the induction of a mitochondrial stress mitokine, FGF21 (Kim et al., 2013). 
Therefore, it is possible that dysfunctional mitochondria generate metabolites or 
myokines that are involved in pathways important for myofibres function during 
exhausting and damaging muscle contraction. Moreover, the detrimental effects of 
anti-oxidants on physical performance underline the important role of mild 
oxidative stress in regulating autophagy and mitochondrial network in skeletal 
muscles.  
We can conclude that autophagy is required for quality control of mitochondria 
during damaging contraction. More studies are required for investigate whether 
block of autophagy leads to possible impaired mitochondrial factor that impinge on 
muscle contraction capacity.  
 
FUTURE WORKS 
 
These works went through several open questions of the autophagy field, solving or 
indicating possible mechanism for each of them. At the same time, some new 
interesting issues came out.  
120 
 
For what concerns constitutive autophagy deficient mice Atg7-/-, now it is important 
to understand the mechanisms that link FGBP1 alteration and MuSK wrong 
localization. We will investigate downstream signals of MuSK, such as ERK pathway, 
that can impinge on transcription factors which possibly regulate FGFBP1 
expression. For the same reason we will study the promoter region of FGFBP1, to 
identify players involved in its regulation. 
The findings obtained with the inducible autophagy deficient mice underlined the 
important role of autophagy in the removal and quality control maintenance of 
mitochondria, during damaging contraction. Now we have to better address which 
type of mitophagy is involved, understanding whether Pink-Parkin, Bnip3 or Nix 
play a role. 
Then it would be interesting to further investigate which are the signals mediated by 
the mitochondria during exercise that are important for muscle homeostasis. 
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